Interaction properties of hnRNP-U family proteins AND SIM:SUMO interaction of the deSUMOylation enzyme SENP7 and the SIMs role in protein functionality by Pratt, Kenny
1 
 
Interaction Properties of hnRNP-U Family 
Proteins 
 
 
 
 
 
 
 
Submitted by Kenny Pratt 
 
 
 
 
 
 
This project is submitted in partial fulfilment of the requirements for the award 
of the MRes 
 
 
 
Supervisors: Dr Roger Grand & Dr Grant Stewart 
2 
 
Abstract 
The efficient repair of DNA damage through highly co-ordinated repair pathways, such as 
homologous recombination (HR), is critical for cell viability. In addition to heterogenous 
nuclear ribonuclearproteins (hnRNPs) exhibiting influences through controlling the 
expression levels of DNA repair proteins via their mRNA processing activities, hnRNPs have 
recently been shown to have roles within the DNA damage response (DDR). Previous studies 
have shown hnRNP-U-like1 (hnRNP-UL1) and hnRNP-U-like2 (hnRNP-UL2) to interact 
with the NBS1 subunit of the MRN complex, p53, CtIP and BLM, all of which have essential 
roles in the DDR.  
 Within this study, interactions between the hnRNP-U-like proteins and p53, CtIP and 
BLM were confirmed both in vitro and in vivo. Binding of p53 was mapped to a BBS-RGG 
domain fragment of hnRNP-UL1, whilst CtIP and BLM required interactions beyond the 
extent of the BBS-RGG domain fragment despite showing that these domains were critical 
for interaction. Regions at the N-terminal and C-terminal ends of BLM were shown to be 
required for binding to hnRNP-UL1 and –UL2, with the BBS-RGG domain of hnRNP-UL1 
being essential for these interactions. The hnRNP-ULs were also shown to interact with one 
another and also with various other hnRNPs in vivo, whilst a novel interaction between PARP 
and the hnRNP-ULs was also identified. This observation, along with the confirmation of the 
protein-protein interactions of various other studies, which reveal a link between hnRNP-U-
like proteins and DNA damage response proteins, have verified the extensive associations 
and potential roles of hnRNP-U-like proteins within the DDR.  
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1.1 Heterogenous Nuclear Ribonuclearproteins (hnRNPs) 
Heterogenous nuclear ribonuclearproteins (hnRNPs) are a large family of diverse proteins 
and whilst exhibiting overlap in structure and function, they do not necessarily exhibit 
extensive homology to one another [1]. They exist as complexes of both protein and RNA, 
and reside largely in the cell nucleus. They were first characterised functionally by their roles 
in mRNA metabolism [2]. Pre-mRNA molecules require processing to become mature 
mRNA, involving packaging, processing, export and localisation to production sites in the 
cytoplasm. This is largely executed by complexes of hnRNPs. In recent years they have been 
implemented in a far wider range of cellular activities, including the DNA damage response, 
which is the focus of this study [1]. During hnRNP’s mRNA processing they facilitate RNA 
binding through complementary nucleotide interactions to their own sequence-specific 
RNAs. hnRNPs involvement in other cellular activities, such as DNA repair, has also shown 
their protein-binding capabilities. This direct protein-protein binding of human hnRNP-U-L1 
and hnRNP-U-L2 was explored during this study. 
1.2 hnRNP-UL1 and –UL2 
hnRNP-UL1 was originally known as E1B-AP5 (adenovirus early region 1B-associated 
protein 5) due to its interaction with the adenovirus E1B-55 kDa protein during the course of 
lytic infection [3]. Its naming as hnRNP-UL1 and also the naming of hnRNP-UL2, 
unsurprisingly relates to its significant homology to hnRNP-U (SAF-A) [3,4]. hnRNP-UL1 
and -UL2 share 43% total homology to one another, with significant homology across various 
domains of the protein (Figure 1.2). The SAP (SAF-A/B, Acinus and PIAS) domain is a 
DNA binding domain, whilst the SPRY (SPIa/Ryanodine receptor domain) has no known 
function of yet [5]. The RGG is a common domain amongst hnRNPs and is characterized by 
closely spaced clusters of Arg-Gly-Gly tripeptide repeats with interspersed aromatic (Phe, 
Tyr) residues. It was originally thought that the RGG box was solely involved in RNA-
binding, however, within hnRNP-A1 and -G it is found in combination with other RNA-
binding elements suggesting other possible roles [6]. Of greater interest to this study were the 
BBS (BRD7-binding site) domain, the RGG (arginine and glycine-rich region) box, and the 
PP (proline-rich region) region as they had already been implicated in some protein 
interactions. The availability of defined fragments of hnRNP-UL1 containing these regions 
allowed the assessment of their importance in protein interactions. 
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 The role of hnRNP-UL1 in mRNA processing and transport were outlined earlier [3]. 
In more recent years it has been found to have roles in the DNA damage response (DDR). 
HnRNP-UL1 has been shown to interact with p53, BRD7, CtIP and BLM [7,8,9,4]. It is 
direct protein-protein interactions with DNA damage response proteins that were investigated 
within this study. 
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Figure 1.2 – Structure of hnRNP-UL1 and -UL2 and its Domains. A schematic 
representation of the full length (WT) hnRNP-U-like proteins and the various fragments 
expressed via in vitro translation or used for GST-pulldown experiments. SAP, SAF-A/B, 
Acinus and PIAS motif; SPRY, SPIa/Ryanodine receptor domain; NK, putative 
nucleoside/nucleotide kinase domain; BBS, BRD7-binding site; RGG, arginine and glycine-
rich region, RNA and ssDNA binding; PP, proline-rich region; Nt, N-terminal fragment; M, 
middle fragment; Ct, C-terminal fragment. Percentages of amino acid homology are indicated 
(total and for coloured domains). Nt, M, Ct, ∆BBS1, ∆BBS2, ∆RGG, ∆PP and BBS-RGG 
refer to hnRNP-UL1 deletion mutants (adapted from [4]). 
 
1.3 The DNA Damage Response 
DNA is continuously coming under a barrage of attack from both endogenous and 
exogenous sources causing varied types of damage, including single-strand lesions, double-
strand breaks and inter-strand crosslinks. Cells have a complex network of repair mechanisms 
to address such damage [10]. If repair is not undertaken efficiently, genomic instability can 
arise which may result in tumorigenesis. p53 has been termed ‘the guardian of the genome’ 
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and is an extensively studied tumour suppressor protein. DNA damage is one of a number of 
upstream activators of p53, which when activated can mediate cell cycle arrest and DNA 
repair [11]. 
Critical regulators of DNA damage response (DDR) pathways are the PI3K 
(phosphatidylinositol 3 kinase) proteins, ATM (ataxia telangiectasia) and ATR (ataxia 
telangiectasia and RAD3-related) proteins, and their activation can trigger activities such as 
cell cycle inhibition, DNA repair or apoptosis, depending on the severity of the DNA 
damage. Simplistically, ATM is activated in response to double-stranded DNA breaks 
(DSBs) commonly caused by ionising radiation (IR), cellular stress and prolonged stalling of 
replication forks. ATR is activated in response to single-stranded DNA lesions induced by 
ultra-violet (UV) radiation [10]. 
The focus of this investigation is repair to double-strand breaks (DSBs), the most 
highly cytotoxic DNA lesions. DSBs are commonly repaired via two mechanisms; 
homologous recombination (HR) and non-homologous end joining (NHEJ). The cell’s choice 
of repair mechanism is dependent upon the stage of the cell cycle as HR requires a section of 
homologous DNA in order to complete error-free repair. However, the sister chromatids 
required for such repair are only available during the S and G2 phases of the cycle. During 
other phases of the cell cycle NHEJ must be employed which is error-prone meaning the 
DNA sequence is often altered/mutated during repair [12]. 
To repair a DSB by HR, a cascade of tightly controlled protein signalling pathways must 
be activated to, firstly, recognise the DNA break, recruit repair factors and then execute 
accurate repair. Within the initial response to a DSB by HR, a distinct focal point around the 
location of the break is created and is often referred to as Ionizing Radiation-Induced Foci 
(IRIF) [13]. The MRN complex plays a critical role as it is the initial sensor of DSBs and 
through its intrinsic capacity to bind DNA it is able to recruit and stimulate ATM [14]. ATM 
is then activated by autophosphorylation at S1981. A large number of other proteins 
contribute to cell-cycle arrest, DNA repair and apoptosis (Figure 1.3a). One such protein is 
the histone H2AX, whose phosphorylation mediates interaction with the scaffold protein 
MDC1. MDC1 acts as a hub for many proteins involved in the DDR to attach and form repair 
foci, including the ubiquitin ligases RNF8, RNF168 and BRCA1 [15]. 
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Figure 1.3a – The Early Responses to DSBs Resulting in the Highly Hierarchical 
Assembly of IRIF. The DSB is sensed by the MRN (MRE11-RAD50-NBS1) complex, 
which recruits the ATM kinase (A) resulting in turn in the recruitment of the scaffold protein 
MDC1 via phosphorylation of the histone H2AX. MDC1 recruits many proteins including the 
ubiquitin ligase RNF8, which ubiquitylates histones (C) to further recruit a second wave of 
repair factors such as 53BP1, the BRCA1 A complex and so on. The assembly of these repair 
proteins controls various DNA and chromatin transactions, ultimately leading to repair of the 
DSB. P: phosphate, M: MRE11, N: NBS1, R: RAD50, Ub: Ubiquitin, A: Abraxas (ABRA1), 
80: Rap80, EXP1: EXPAND1 [16]. 
 
12 
 
1.4 DNA End Resection During HR (Homologous Recombination) 
Following the initial response to DSBs and accumulation of such repair foci, DNA end 
resection of the DSB is required to reveal ssDNA, which triggers ATR-dependent checkpoint 
signalling and DSB repair by HR [17]. This is essential in the recruitment of the homologous 
region of the complementary sister DNA strand upon which the error-free repair by HR is 
based. Once the ends of the break are resected, ssDNA is bound by the RPA protein complex, 
which subsequently recruits the Rad51 recombinase forming a nucleoprotein filament. Rad51 
is responsible for the recruitment of the complementary sister strand, resulting in the  
A
B
C
D
E
 
Figure 1.3b – The DNA Formations and Processing During DSB Repair by HR. A DSB 
occurs and repair foci form (A), followed by end resection (B) and the strand invasion by the 
recruited complementary sister DNA strand. DNA synthesis follows creating D-loop 
structures (C). Ligation of the DNA ends causes the formation of Holliday junctions (HJ) (D). 
Finally, these are junctions are resolved, which can result in the exchange (crossover) of 
DNA between sister chromatids (E) (adapted from [18]). 
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formation of displacement-loops (D-loops) and Holliday junctions (Figure 1.3b). A new 
strand is then synthesised by DNA polymerase, the two ends joined by a DNA ligase to repair 
the DSB and finally, the intermediate HJ structures are resolved [18]. 
 
1.5 CtIP in DNA End Resection  
DNA end resection is carried out by a series of enzymes including nucleases and 
helicases. The C-terminal-binding protein interacting protein (CtIP), as the name suggests, 
was originally identified for its capability to bind CtBP (C-terminal-binding protein) [19]. 
CtIP is an endonuclease and through its interaction with the MRN complex (which also has 
its own exo- and endo-nuclease activity) it is able to mediate DSB end resection [17]. As well 
as interacting with the MRN complex, CtIP is known to be one of the phosphorylation targets 
of ATM and also binds to BRCA1 during responses to DSBs [20]. It is clear that CtIP is 
essential for resection and therefore efficient repair by HR. Studies have also shown that the 
phosphorylation of CtIP by ATM at serine residue 327 mediates the interaction with BRCA1 
and this subsequently controls choice of the DSB repair pathway (either HR or NHEJ) 
depending on stage of the cell cycle [21,22]. 
 
1.6 BLM (Bloom Syndrome Protein) in DNA End Resection  
Another protein central to DNA end resection and recombination is the Bloom Syndrome 
protein (BLM). BLM is a member of the RecQ family of DNA helicases. It is able to unwind 
dsDNA in the 3’ to 5’ direction and its role within sites of DSB repair stems from its affinity 
for recombination intermediates, such as D-loops and Holliday junctions [23]. BLM is 
recruited to repair foci and co-localises with γ-H2AX, clearly showing involvement in the 
DDR [24]. 
RecQ helicases are thought to possess both pro-recombinase and anti-recombinase 
activities. The prevention of excessive HR is indeed critical in avoiding genome 
rearrangements that may harm the cell. BLM was first recognized for its anti-recombinase 
activity [25]. Mutations in (i.e. loss of function of) BLM lead to the extremely rare, 
autosomal recessive disease Bloom Syndrome (BS). Of the 240 cases identified worldwide, 
symptoms include severe growth retardation, photosensitivity, immunodeficiency, fertility 
problems, and predisposition to cancer, as would be expected with a defect in DNA repair 
pathways [26]. Due to loss of the anti-recombinase activity of BLM, levels of HR increase 
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ultimately leading to genetic instability [27]. Further evidence of anti-recombinase activity is 
shown through its interaction with Rad51, subsequently inhibiting polymerisation of Rad51 
required for location of the complementary sister chromatid [24]. Recent evidence, alluding 
to BLM’s pro-recominogenic roles, has shown that it interacts directly with the 5’ to 3’ 
dsDNA exonuclease, Exo1, resulting in stimulation of its resection activity [28]. BLM has 
also been shown to have roles within the later stages of HR as it forms a complex with 
Topoisomerase IIIα, which is able to resolve Holliday junctions in the correct manner 
reducing the number of potentially harmful crossover events [29]. 
 
1.7 hnRNPs in DNA Damage Repair (DDR) 
In recent years, more and more evidence has accumulated which implicates hnRNPs in 
coordinating repair pathways both through protein-protein interactions and the regulation of 
transcription of repair and stress response mRNA [1]. Given the extensive roles of hnRNPs in 
mRNA processing it is unsurprising that they play a pivotal role in repair pathways by 
controlling the expression levels of DNA repair proteins. More unexpected is their regulation 
by direct interaction with proteins involved in repair processes. Many examples of this have 
now been recognised. Firstly, roles within NHEJ pathway have been suggested through 
hnRNP-B1’s interaction and inhibition of DNA-dependent protein kinase (DNA-PK) and 
hnRNP-C1/C2’s interaction with the Ku antigen (Ku) [30,31]. hnRNP-K was shown to be 
phosphorylated in response to DSBs by ATM and to act as a co-factor to p53 for 
transcriptional control of DNA repair factors [32]. p53 has also been shown to interact with 
hnRNP-UL1, the hnRNP of main focus to this study [7]. In direct relation to DSB repair 
pathways, hnRNP A1, A18, A2/B1, C1/C2, K and P2 have been shown to be involved in 
regulating the choice between HR and NHEJ [1]. 
1.8 hnRNP-UL1 and –UL2 in the DDR 
The evidence for hnRNP-UL1’s involvement in the DDR is very strong. It has been shown to 
interact with a C-terminal region of p53 and to reduce p53’s activities as a transcription factor 
[7]. RPA70 and RPA32 are principle components of the RPA complex which binds ssDNA 
during HR. hnRNP-UL1 was found to bind directly to RPA70 and RPA32, and during 
adenovirus infection was required for phosphorylation of H2AX [33]. 
 Previous work completed in conjunction with our laboratory was published whilst this 
study was on-going [4]. It showed that both hnRNP-UL1 and –UL2 bound to NBS1 of the 
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MRN complex. The interaction was shown to be between the C-terminus of NBS1 and the 
middle portion of hnRNP-UL1 (specifically the BBS-RGG region). The study also 
highlighted hnRNP-UL1’s requirement in stimulating DNA end resection and for effective 
HR repair. When RNA was depleted in cells, the interdependent recruitment of hnRNP-UL1 
and –UL2 (i.e. as part of the same complex) to sites of DNA damage was observed. The 
contribution of hnRNP-UL1 to ATR-dependent signalling during DNA repair by promoting 
DSB resection was also alluded to. This influence was mediated downstream of MRN and 
CtIP by the recruitment of BLM to sites of laser-induced or camptothecin (CPT)-induced 
damage [4]. The study also showed association of hnRNP-UL1 with BLM. Such direct 
protein-protein interactions with proteins involved in the DDR was the focus of this study. 
1.9 Aims 
Therefore, based on the previous work discussed above the principle aims of this study were: 
1. To investigate the protein-protein interactions of hnRNP-UL1 and –UL2 with proteins 
involved in the DDR. 
2. To further characterise the known interactions of hnRNP-UL1 with p53 and BLM.  
3. To try to identify novel interacting partners of hnRNP-UL1 and –UL2. 
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2. Materials and Methods 
 
2.1 Tissue Culture Techniques 
 
2.1.1 Maintenance of Human Cell Lines 
Cell lines were maintained in a 5% CO2 incubator at 37ºC (Table 2.1). Cell lines were 
sustained in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma), supplemented with 7% 
v/v foetal calf serum (FCS) (PAA Laboratories). 
 
Table 2.1 Human Cell Lines Used in the Study. 
Cell line ATCC number Additional Information 
U20S HTB-96 Human epithelial osteosarcoma cell line (origin = bone). 
Hela CCL-2 Human epithelial adenocarcinoma cell line (origin = 
cervix). Contains human papilloma virus. 
DLD-1 CCL-221 Human epithelial osteosarcoma cell line (origin = bone). 
 
2.1.2 Human Cell Culture 
The passage of adherent cell lines was achieved by washing twice with PBS (phosphate 
buffered saline) (Sigma), trypsinisation using 5 mls of 0.05% trypsin-
ethylenediaminetetraacetic acid (EDTA) (Invitrogen) and incubated at 37ºC until cells lost 
adherence to the tissue culture dish. 10 mls of media was added deactivating the trypsin, 
followed by centrifugation at 1,400 revolutions per minute (rpm) at room temperature for 4 
minutes and the cell pellet resuspended media and replated at required density. 
 
2.2 Protein Chemistry Techniques 
 
2.2.1 Harvesting Human Adherent Cells 
For harvesting cells for Glutathione S-Transferase (GST) pulldown or co-
immunoprecipitation assays, media was removed and cells washed twice in cold 0.15M 
saline. Cells were scraped from the surface of the tissue culture dish, resuspended in cold 
saline and centrifuged at 1,500 rpm at 4ºC for 4 minutes. For GST pulldown the cell pellet 
was resuspended in buffer A (PBS/2mMEDTA/1%Triton X100). For co-
immunoprecipitation the cell pellet was resuspended in NETN buffer (0.15M NaCl / 2mM 
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EDTA / 1%NP40 / 40mM Tris (pH 7.4)). The cells were then homogenised using a Wheaton-
Dounce hand homogeniser and sonicated twice to disrupt cell membranes and DNA. The 
lysate was cleared via centrifugation at 3,000 rpm at 4ºC for 5 minutes. The supernatant was 
centrifuged twice more, once at 13,000 rpm, 4ºC for 5 minutes and then again at 45,000 rpm, 
4ºC for 30 minutes and in each case the pellet discarded. 
 
2.2.2 Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Proteins were separated according to molecular weight via SDS-PAGE. 10% polyacrylamide 
gels were made using the following components: 30% w/v acrylamide (37:5:1 BIS-
acrylamide) (Severn Biotech), 0.1M Tris (Melford)/ 0.1M Bicine (pH8.3) (Severn Biotech), 
0.1% SDS (Severn Biotech), 0.3% N, N, N’, N’-Tetramethylethylenediamine (TEMED) 
(Severn Biotech), 0.6% ammonium persulphate (APS) (Sigma) and deionised water. Gels 
were cast in an assembled apparatus and wells filled with running buffer (0.1M Tris/ 0.1M 
Bicine (pH8.3) and 0.1% w/v SDS). Cell lysate, GST-pulldown and co-immunoprecipitation 
samples were prepared for running on polyacrylamide gels by adding an equal amount of 
Laemmli sample buffer (25% v/v glycerol (BDH Laboratories), 5% β-mercaptoethanol, 2% 
w/v SDS, 0.01% w/v bromophenol blue (BDH Laboratories) and 65mM Tris (pH 6.8)). 
Samples were then heated at 95ºC for 5 minutes, centrifuged at 13,000rpm for 1 minute, and 
loaded in to the gel wells along with a molecular weight marker. Gels were typically run 
overnight at 8-15mA for 16 hours.  
 
2.2.3 Visualisation of In Vivo Proteins Separated by SDS-PAGE 
The protein quality of SDS-PAGE run samples was assessed by staining the polyacrylamide 
gels for 1 hour in 0.1% w/v Coomassie brilliant blue R-250 (Sigma) in 25% methanol 
(Sigma), 10% acetic acid (Fisher Scientific). Gels were then destained in rapid Coomassie 
destain (acetic acid/methanol/water (1:3:6 v/v ratio)) overnight, and assessed after destaining 
was deemed sufficient. 
 
2.2.4 Visualisation of In Vitro Translated Proteins Separated by SDS-PAGE 
The radioactive, [35S]-labelled in vitro translated proteins (see Section 2.5.1) were visualised 
by placing the gels in 1M sodium salicylate (Sigma), drying them under vacuum at 80ºC for 2 
hours and exposure to autoradiography film (Kodak) for a suitable time period.  
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2.2.5 Visualisation of Proteins on Nitrocellulose Membranes 
Proteins transferred from polyacrylamide gels on to nitrocellulose membranes were stained 
with Ponceau-S Stain consisting of 0.1% Ponceau-S (Sigma) and 3% trichloroacetic acid 
(TCA) (BDH Laboratories) for 30 seconds. Nitrocellulose membranes were then thoroughly 
washed with deionised water for visualisation and then further washed in Tris-Buffered 
Saline Tween-80 (TBST) (1% Tween-80 (Sigma), 0.15M NaCl (Sigma), 50 mM Tris, HCl 
pH 7.4 (Fisher Scientific)) to remove the remaining stain. 
 
2.2.6 GST Pulldown Assay 
These assays were utilised to assess direct protein-protein interactions. Cell lysates as 
prepared in section 2.2.1 were incubated with 25µg GST-fusion proteins (Table 2.2.6) and 
left rotating at 4ºC (this time period was overnight for cell lysates and 3 hours for incubation 
with 35S-labelled in vitro translated proteins). 50µl of resuspended glutathione-agarose beads 
(Sigma) were added and incubated for 90 minutes at 4ºC on a rotator to allow protein-protein 
complexes to bind to the beads. Samples were then centrifuged at 3,000rpm, 4ºC for 1 minute 
and supernatant discarded. Samples were then washed 4 times in buffer A and once in buffer 
B (2mM EDTA (Sigma) in PBS), any residual buffer was removed and 60µl of 25mM 
glutathione pH 8.2 (BDH Laboratories) was added and left to incubate for 1 hour at 4 ºC 
under gentle agitation. Samples were then centrifuged at 13,000rpm, 4ºC for 1 minute and the 
supernatant retained in a fresh Eppendorf tube. A further 30µl of glutathione was added to the 
beads and incubated at 4ºC for a further 30 minutes. The samples were centrifuged again at 
13,000rpm, 4ºC for 1 minute and the supernatant pooled with the previous one. 25µl of 
Laemmli sample buffer was added to each sample, heated at 95ºC for 5 minutes, centrifuged 
at 13,000rpm for 1 minute and loaded on to a 10% SDS-polyacrylamide gel (Section 2.2.2). 
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Table 2.2.6 - GST-fusion Proteins Used in this Study. Indicated are the GST-fusion 
proteins used in this study, the amino acid lengths they incorporate and their source. 
GST-fusion protein Incorporating Source 
GST-hnRNP-UL1 hnRNP-UL1 wild-type 
fragment aa 1-856 
Produced prior to this 
study 
GST-hnRNP-UL1-
BBSRGG 
hnRNP-UL1 fragment aa 
445-695 
Produced prior to this 
study 
GST- hnRNP-UL1-673 hnRNP-UL1 fragment aa 
1-673 
Produced prior to this 
study 
GST- hnRNP-UL2 hnRNP-UL2 wild-type 
fragment aa 1-747 
Produced prior to this 
study 
GST-p53 p53 wild-type fragment aa 
1-393 
Produced prior to this 
study 
GST-CtIP CtIP wild-type fragment aa 
1-897 
Produced prior to this 
study 
GST-BLM wt BLM wild-type fragment 
aa 1-1417 
Produced prior to this 
study 
GST-BLM fragment 1 BLM fragment aa 1-212 Produced prior to this 
study and during this study 
GST- BLM fragment 2 BLM fragment aa 191-660 Produced prior to this 
study 
GST- BLM fragment 3 BLM fragment aa 621-
1041 
Produced prior to this 
study and during this study 
GST- BLM fragment 4 BLM fragment aa 1001-
1417 
Produced prior to this 
study 
 
 
2.3 Immunological Techniques 
 
2.3.1 Western Blotting 
Following fractionation of proteins by SDS-PAGE, proteins were transferred on to 
nitrocellulose membrane via the following method. Transfer cassettes were assembled 
containing the following layers: a sponge, Whatmann 3MM blotting paper, nitrocellulose 
21 
 
membrane (Pall corporation), SDS-PAGE gel, Whatmann blotting paper and a sponge (all 
equipment was pre-immersed in transfer buffer containing 20% v/v methanol, 0.19M glycine 
and 0.05M Tris). The cassette was then placed in a transfer tank filled with transfer buffer 
and a 280mA current applied for 6 hours. Membranes were blocked by placement in 5% 
skimmed dried milk (Marvel) in TBST for 30 minutes. Primary antibodies (Table 2.3.1a) 
were diluted in 5% skimmed dried milk in TBST and incubated with the membranes 
overnight at 4ºC under gentle agitation. The membranes were then washed 3 times for 15 
minutes in TBST. Membranes were then incubated with secondary antibodies (Table 2.3.1b) 
conjugated to horseradish peroxidise (HRP) in 5% skimmed dried milk in TBST for 2 hours 
at room temperature. Membranes were washed again in TBST 6 times for 5 minutes each 
time. Enhanced chemiluminescence (ECL) reagent (Millipore or GE Healthcare) was added 
for 1 minute and the blot exposed to autoradiography film (Kodak) for a suitable time period. 
 
Table 2.3.1a – Primary Antibodies Used in this Study. Indicated are the primary antibodies 
used in this study, their antigens, dilution, use, species of origin and source. 
Antibody Antigen Dilution Use Species Company/Source 
BLM BLM 1 in 500 WB, IP Goat Bethyl 
hnRNP-U hnRNP-U 1 in 1000 WB Goat SantaCruz 
hnRNP-H hnRNP-H 1 in 1000 WB Goat SantaCruz 
hnRNP-K hnRNP-K 1 in 1000 WB Rabbit  SantaCruz 
hnRNP-
UL1 
hnRNP-
UL1 
1 in 1000 WB, IP Rabbit Produced ‘in 
house’ 
PARP PARP 1 in 1000 WB Mouse SantaCruz 
CtIP CtIP 1 in 1000 WB, IP Mouse Richard Baer 
D01 (p53) p53 1 in 1000 WB, IP Mouse David Lane 
(N.B. WB – Western blot; IP – immunoprecipitation) 
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Table 2.3.1b – Secondary Antibodies Used in this Study. Indicated are the secondary 
antibodies used in this study, their antigens, dilution, use, species of origin and source. 
Antibody Antigen Dilution Use Species Company/Source 
Mouse Mouse 
IgG 
1 in 2000 WB Goat Dako Laboratories 
Rabbit Rabbit IgG 1 in 3000 WB Swine Dako Laboratories 
Goat Goat IgG 1 in 2000 WB Rabbit Dako Laboratories 
(N.B. WB – Western blot) 
 
2.3.2 – Co-Immunoprecipitation (CoIP) 
Cell lysate, as prepared in Section 2.2.1, was incubated with 5-20µl of primary antibody 
(Table 2.4.1a) on rotation at 4ºC overnight. Samples were then centrifuged at 45,000rpm, 4ºC 
for 30 minutes and the pellet discarded to remove proteins that had become insoluble 
overnight. 40µl of Protein G-agarose beads (Sigma) were added to samples and rotated at 4ºC 
for 90 minutes. The samples were then centrifuged at 3,000rpm, 4ºC for 1 minute and 
supernatant discarded. After 4 washes of the samples in NETN buffer and removal of the 
supernatant each time, 50µl of Laemmli sample buffer was added, heated at 95ºC for 5 
minutes, centrifuged at 13,000rpm for 1 minute and resolved by SDS-PAGE. 
 
 
2.4 Molecular Biology Techniques 
 
2.4.1 In Vitro Translation Protein Production 
The TNT Coupled Reticulocyte Lysate Systems kit (Promega Corporation) was used to 
produce proteins with [35S]-labelled, radioactive methionine incorporated within them. The 
components listed in Table 2.5.1 were added to a sterile 1.5ml Eppendorf tube. The volume 
was made up to 50µl with sterile distilled water and incubated at 30ºC for 90 minutes. 3µl 
aliquots were then subjected to SDS-PAGE, the gels placed in 1M sodium salicylate (Sigma), 
dried and exposed to autoradiography film for a suitable time period to assess the quality of 
proteins produced. The remainder of the sample were frozen until required. 
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Table 2.4.1 – Reaction Mixture Required for In Vitro Translation Protein Production. 
Component Volume added (µl) 
TNT Rabbit Reticulocyte Lysate 25 
TNT Reaction buffer 2 
TNT RNA Polymerase 1 
Amino acid mixture (minus methionine) 1mM 1 
[35S]-labelled methionine (1,000Ci/mmol at 10MCi/ml) 2 
RNasin Ribonuclease Inhibitor (40µg/µl) 1 
DNA template (0.5µg/µl) 2 
 
2.4.2 GST-Fusion Protein Production 
10mls of Luria Bertani (LB)-broth (10g/L tryptone (Fischer Scientific), 10g/L NaCl and 5g/L 
yeast extract (Fischer Scientific)) supplemented with 100µg/ml ampicillin (Sigma) was 
inoculated with BL21 E. Coli transformed with gene constructs (Table 2.4.2), and left in an 
orbital incubator at 37ºC overnight. 5mls of LB-broth culture was then added to 500mls of 
LB-broth supplemented with 100µg/ml ampicillin, and grown at 220rpm, 37ºC until cultures 
reached an optical density of 0.6-0.7 absorbency units at a wavelength of 600nm. 0.5mM 
isopropyl –D-1thiogalactopyranoside (IPTG) (Sigma) was then added to the cultures and 
grown for a further 3 hours at 30ºC, 220 rpm. Following incubation, cultures were 
centrifuged at 6,000rpm for 15 minutes, supernantants discarded and pellets frozen at -80ºC 
until required. 
 The pellets were resuspended in 30mls of Buffer A (2mM EDTA, 1% Triton X100 
(Sigma) in PBS) and sonicated twice for 30 seconds (1 minute interval), then centrifuged at 
18,000rpm for 5 minutes and the pellet discarded. The supernatant (bacterial cell lysate) was 
further centrifuged at 18,000rpm for 30 minutes and the pellet discarded. 2mls of 
PBS:glutathione-agarose beads (50:50) were added to the supernatant and rotated for 3 hours 
at 4ºC. Samples were then centrifuged at 1,500rpm for 5 minutes, 1ml of PBS:glutathione-
agarose beads (50:50) added to the supernatant and rotated at 4ºC for a further hour. The 
pelleted beads were washed three times in 50mls of Buffer A, centrifuging at 2,000rpm for 5 
minutes at 4ºC each time. A wash was then completed in 50 mls of Buffer B. To the beads, 
2mls of 25mM glutathione (pH8.2) was added and rotated at 4ºC for 1 hour. This was 
followed by centrifugation at 2,000 rpm for 5 minutes and supernatant retained. Supernatants 
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were then subjected to dialysis at 4ºC overnight via placement in to dialysis tubing 
surrounded by a buffer containing 150Mm NaCl, 25mM Tris (pH7.5) and 1mM dithiothreitol 
(DTT) (Sigma). 
 
Table 2.4.2 – Gene Expression Constructs Used for GST-Fusion Protein Production.  
Gene Vector Source 
BLM Fragment 1 (aa 1-212) pGEX-4T-1 Dr Sengupta [34] 
BLM Fragment 3 (aa 621-1041) pGEX-4T-1 Dr Sengupta 
 
2.4.3 – Preparation of Samples for Mass Spectrometry 
GST-pulldown samples were prepared as in section 2.2.7 until the final wash with buffer B 
(2mM EDTA (Sigma) in PBS) and any residual buffer was removed. 20µl of SDS buffer 
(50mM ammonium bicarbonate, 8M Urea, and 5% SDS) and 5µl of 50mM DTT solution was 
added to the beads before heating at 56ºC for 1 hour. 10µl of 100mM iodoacetamide solution 
(Sigma) was added and left at room temperature for 30 mins, before subsequent addition of 
5µl Laemmli sample buffer. Samples were centrifuged at 3,000rpm for 1 minute and the 
supernatants subjected to SDS-PAGE at 200V for an appropriate time period, along with high 
molecular weight marker (Fermentas) on pre-cast 4-20% polyacrylamide gels. The running 
buffer was composed of 20ml NUPAGE MOPS SDS Running Buffer (x20) (Invitrogen) in 
500ml sterile water). The gel was stained overnight in Colloidal Coomassie blue (0.1% 
Coomassie blue G250, 20% methanol, 1.6% orthophosphoric acid, 8% ammonium 
persulphate). 
 The gel was destained in 1% acetic acid (BDH) before sectioning control and sample 
lanes in to 15-20 gel pieces, placing them in sterile Eppendorf tubes and adding 200µl 50% 
acetonitrile 50mM NH4HCO3 (Sigma) and incubating at 37ºC for 45 minutes under gentle 
agitation. Three washes were made in 200µl 10% acetonitrile 50mM NH4HCO3 for 15 
minutes at room temperature, before drying the gel sections. 20µl trypsin (Roche) was then 
added to samples for 1 hour at 37ºC to digest proteins within the gel sections. 20µl 10% 
acetonitrile 50mM NH4HCO3 was added and samples left overnight. 
 Supernatants were collected and remaining gel sections incubated in 30µl 3% formic 
acid at 37ºC for 1 hour. The subsequent supernatant was then added to the previous one, the 
addition of 3% formic acid and 1 hour incubation at 37ºC repeated and combined 
supernatants stored at -20ºC until samples were analysed by mass spectrometry. 
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3.1 – p53, CtIP and BLM Interact with [35S]-Labelled hnRNP-UL1 and hnRNP-UL2 In 
Vitro 
Previous studies had shown hnRNP-UL1 and –UL2 to associate with various proteins with 
crucial roles within the DNA damage response, including p53, CtIP and BLM [7,4]. To 
further investigate the interactions of hnRNP-ULs with these proteins, GST pulldown assays 
were performed. GST-fusion proteins were incubated with [35S]-labelled in vitro translated 
forms of hnRNP-UL1, -UL2, and also various fragments of hnRNP-UL1. The resulting 
protein complexes formed were isolated using glutathione-agarose beads. After separation by 
SDS-PAGE protein bands were visualised by autoradiography. This showed that hnRNP-
UL1 and –UL2 interacted directly with p53, CtIP and BLM in vitro (Figure 3.1). p53 was 
included as a positive control since it had previously been shown to interact directly with 
hnRNP-UL-1 [7]. 
Use of various [35S]-labelled fragments of hnRNP-UL1 (shown in Figure 1.2) allowed 
the assessment of which regions/domains of the protein were required for binding to p53, 
CtIP and BLM. The autoradiographs shown in Figure 3.1 B-D were subjected to 
densitometric scanning in an attempt to quantitate the interaction (shown in Figure 3.1 D). 
The middle (M) and C-terminal (Ct) regions exhibited interaction with each of the three 
proteins, whilst the N-terminal region of hnRNP-UL1 showed no interaction. Deletion of the 
RGG domain severely perturbed the ability of hnRNP-UL1 to bind the three proteins, as did 
the larger deletion (ΔBSS2) of the BBS domain. However, a BBS-RGG domain fragment 
alone failed to show significant interaction with CtIP or BLM whilst binding to p53. This 
suggests regions of hnRNP-UL1 other than the BBS and RGG domains are required for 
binding CtIP and BLM. Deletion of the polyproline-rich (PP) region also reduced binding 
more significantly with CtIP and BLM than with p53. Finally, it is shown that hnRNP-UL2 
binds p53 with two-fold better efficiency than both CtIP and BLM (Figure 1.1). 
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Figure 3.1 – hnRNP-UL1 and –UL2 Bind p53, CtIP and BLM. A-D) [35S]-labelled 
proteins were incubated with the indicated GST fusion proteins and protein complexes 
formed isolated with glutathione-agarose beads, before subsequent elution with glutathione. 
The eluted proteins were fractionated by SDS-polyacrylamide gel electrophoresis and 
revealed by autoradiography. In B, C and D the upper panel shows inputs, the central panel 
the bound protein and the lower panel protein bound to GST. E) Densitometric scanning was 
used to quantify the proportion of each of the proteins bound to the indicated GST-fusion 
protein (these data are derived from the autoradiographs shown in B-D). 
E
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Figure 1.2 – Structure of hnRNP-UL1 and -UL2 and its Domains. A schematic 
representation of the full length (WT) hnRNP-U-like proteins and the various fragments 
expressed via in vitro translation or used for GST experiments. SAP, SAF-A/B, Acinus and 
PIAS motif; SPRY, SPIa/Ryanodine receptor domain; NK, putative nucleoside/nucleotide 
kinase domain; BBS, BRD7-binding site; RGG, arginine and glycine-rich region, RNA and 
ssDNA binding; PP, proline-rich region; Nt, N-terminal fragment; M, middle fragment; Ct, 
C-terminal fragment. Percentages of amino acid homology are indicated (total and for 
coloured domains). Nt, M, Ct, ∆BBS1, ∆BBS2, ∆RGG, ∆PP and BBS-RGG refer to hnRNP-
UL1 deletion mutants (adapted from [4]). 
 
3.2 – The N-Terminal and C-Terminal Regions of BLM Interact with [35S]-Labelled 
hnRNP-UL Proteins In Vitro 
To further assess the binding of the BLM helicase with hnRNP-UL1, GST pulldowns were 
performed using GST-BLM fragments (shown in Figure 3.2a). Various GST-BLM fragments 
were expressed in E. coli (Table 2.5.2), purified and resolved by SDS-PAGE. SDS-PAGE 
gels were then stained with Coomassie Blue to assess the purity of the GST-fusion proteins 
produced (Figure 3.2b). Other GST-fusion proteins were already available within the 
laboratory. GST-fusion proteins were incubated with [35S]-labelled in vitro translated forms 
of hnRNP-UL1, -UL2, and the various fragments of hnRNP-UL1 described in Figure 1.2. 
The resulting protein complexes formed were isolated using attachment of the GST moiety to 
glutathione-agarose beads. After separation by SDS-PAGE protein bands were visualised by 
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autoradiography, showing that hnRNP-UL1 and –UL2 interacted with BLM fragments 1 and 
4 in vitro (Figure 3.2c(A)).  
Once again, use of various [35S]-labelled fragments of hnRNP-UL1 allowed the 
assessment of which regions/domains of the protein interacted with BLM fragments 1 and 4. 
Whilst loss of the BBS, RGG and PP domains/regions significantly reduced the binding of 
hnRNP-UL1, loss of the BBS domain appeared to affect the binding of BLM fragment 4 
significantly more than fragment 1 (Figure 3.2c (B-D)). BLM fragment 1 exhibited very 
efficient binding to the BBS-RGG domain fragment alone, whilst BLM fragment 4 did not. 
This suggests that whilst the BLM fragment 4 critically requires the BBS and RGG domains 
for binding, they do not permit significant interaction alone. 
1-1417 (WT)
1-212 
(Fragment 1)
191-660 
(Fragment 2)
621-1401 
(Fragment 3)
1001-1417 
(Fragment 4)
Helicase RQC HRDC
 
Figure 3.2a – Structure of BLM and its Domains. A schematic representation of BLM and 
the GST-BLM fragments (numbered 1-4) used in this study. Amino acid numbers are 
indicated above the full length (WT) BLM and various domains below. RQC, RecQ carboxy-
terminal; HRDC, Helicase and Rnase D C-terminal (adapted from [35]). 
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Figure 3.2b – Assessment of the Protein Purity of the GST-BLM Fragments Produced 
in this Study. The required plasmid DNA constructs were transformed in to BL21 E. Coli to 
produce the indicated GST-fusion proteins. The proteins were purified using gluitathione 
agarose, resolved by SDS-PAGE, Coomassie Blue stained and subsequently destained to 
assess protein purity. The 3 tracks for each fragment show different elutions from the 
glutathione agarose as described in the Methods section. 
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Figure 3.2c – The N-Terminal and C-Terminal Regions of BLM are Required to 
Interact with hnRNP-UL Proteins. A-C) [35S]-labelled proteins were incubated with the 
indicated GST fusion proteins and protein complexes isolated with glutathione-agarose 
beads, before subsequent elution with glutathione. The eluted proteins were fractionated by 
SDS-polyacrylamide gel electrophoresis and revealed by autoradiography. D) Densitometric 
scanning was used to quantify the proportion of each of the proteins bound to the indicated 
GST-fusion protein. 
D 
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3.3 – hnRNP-UL Proteins Homo- and Heterodimerize In Vitro 
Within a previous study, depletion of either hnRNP-UL1 or -UL2 caused defects in DNA-end 
resection during DSB repair, showing they are not redundant in their actions despite sharing 
considerable amino acid sequence homology (Figure 1.2) [4]. Their recruitment to DSB sites 
was also shown to be largely interdependent, suggesting that they are probably recruited 
within the same protein complex. Therefore, we investigated the interaction of hnRNP-ULs 
with themselves and one another via the same method of GST pulldown, employing the use 
of GST-fusion proteins incubated with [35S]-labelled in vitro translated forms of hnRNP-
UL1, -UL2, and also various fragments of hnRNP-UL1. Results showed that hnRNP-UL1 
homodimerizes and hnRNP-UL1 and –UL2 heterodimerize with one another (Figure 3.3). It 
appears that the RGG domain was most critical for interaction of hnRNP-UL1 both with itself 
and with hnRNP-UL2.  
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Figure 3.3 – hnRNP-UL Proteins Homo- and Heterodimerize. A-B) [35S]-labelled 
proteins were incubated with the indicated GST fusion proteins and protein complexes 
formed isolated with glutathione-agarose beads, before subsequent elution with glutathione. 
The eluted proteins were fractionated by SDS-polyacrylamide gel electrophoresis and 
revealed by autoradiography. C) Densitometric scanning was used to quantify the proportion 
of each of the proteins bound to the indicated GST-fusion protein. 
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3.4 - p53, CtIP, BLM and PARP Interact with hnRNP-UL1 In Vivo 
To confirm that p53, CtIP, and BLM associate with hnRNP-UL1 in vivo, co-
immunoprecipitation assays were performed. Cell lysates were incubated with the appropriate 
antibodies and subsequent immune-complexes were isolated using Protein-G agarose beads 
and subjected to Western blotting for the indicated proteins (Figure 3.4a). Figure 3.7A shows 
that hnRNP-UL1 co-immunoprecipitated with antibodies against p53, CtIP and BLM 
confirming their in vivo association. A reciprocal experiment showed p53 co-
immunoprecipitated with antibodies against hnRNP-UL1 (Figure 3.4a (B)).  
 
 
Figure 3.4a – p53, CtIP and BLM Interact with hnRNP-UL1 In Vivo. DLD1 cell lysates 
were incubated with the indicated antibodies, protein-protein complexes were isolated using 
Protein-G beads and subjected to Western blotting. 
 
 
A further co-immunoprecipitation experiment employing an antibody against hnRNP-UL1 
and subsequent immunoblotting for PARP showed their interaction with one another in vivo 
(Figure 3.4b (A)). A GST-pulldown experiment also showed PARP to interact with hnRNP-
UL1, hnRNP-UL2 and a smaller fragment of hnRNP-UL1 (hnRNP-UL1-673) but not with 
the BBS-RGG fragment (Figure 3.4b (B)). 
PARP PARP
A B
 
Figure 3.4b – PARP Interacts with hnRNP-UL1 In Vivo. A) U20S cell lysates were 
incubated with the indicated antibodies, protein-protein complexes were isolated using 
Protein-G beads and subjected to Western blotting. B) U20S cell lysates were incubated with 
the indicated GST-hnRNP-U-like fusion proteins. Protein complexes were isolated with the 
use of glutathione-agarose beads and subsequent elution with glutathione before being 
subjected to Western blotting for PARP. 
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3.5 - hnRNP U-like Proteins Bind Other hnRNPs In Vivo 
Many studies have shown hnRNP proteins to interact with one another [36,37,38]. Within 
this study it has been shown that the hnRNP-UL proteins interact with one another and also 
homodimerize. GST-pulldown assays were performed to investigate whether other hnRNPs 
interact with the hnRNPUL proteins. Hela cell lysates were incubated with GST-fusion 
proteins and resulting protein complexes were isolated using glutathione-agarose beads 
before subjection to Western blotting for various proteins, along with GST protein alone and 
cell lysate alone as non-specific binding and positive controls, respectively. hnRNP-UL1 and 
–UL2 were shown to bind hnRNP-H, -K and -U(SAFA) (Figure 3.5 (A)). Figure 3.9B shows 
the BBS-RGG region being enough to pull down hnRNP-H and –U.  
hnRNP-H
hnRNP-K
hnRNP-U (SAFA)
hnRNP-H
hnRNP-U (SAFA)
A
B
 
Figure 3.5 - hnRNP U-like Proteins Bind Other hnRNPs. Hela cell lysates were incubated 
with the indicated GST-hnRNP-U-like fusion proteins. Protein complexes were isolated with 
the use of glutathione-agarose beads and subsequent elution with glutathione before being 
subjected to Western blotting. 
 
3.6 – Mass Spectrometry Tentatively Highlighted Some Other hnRNP-UL1 Interacting 
Proteins Involved in DNA Damage Repair/Processing 
A pulldown assay was completed employing the GST-hnRNP-UL1-BBS-RGG fragment. 
Protein complexes formed were isolated and subjected to SDS-PAGE. Control and sample 
lanes within the gel were then sliced in to sections, digested with trypsin and the resulting 
peptides assessed by mass spectrometry. This tentatively identified other hnRNPs and various 
proteins involved in the DNA damage response (DDR) that associate with hnRNP-UL1. 
These included proteins already identified in the study, such as hnRNP-UL1, hnRNP-UL2 
and hnRNP-U (SAFA), as well as hnRNPs: -D0, -R and -A/B. Further proteins included 
DNA-damage-binding protein 1, ATM, E3 ubiquitin-ligase SHPRH, E3 ubiquitin-protein 
ligase TTC3 and E3 ubiquitin-protein ligase BRE1A.  
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4. Discussion 
Previous studies carried out in conjunction with our laboratory had shown hnRNP-UL1 and 
hnRNP-UL2 to associate with various proteins with important roles within the DNA damage 
response [4]. These included direct binding of the NBS1 subunit of the MRN complex, as 
well as, the co-immunoprecipitation of CtIP and BLM helicase. The interaction with the 
MRN complex was crucial for their recruitment to DSB sites and association with BLM 
facilitated its recruitment to DSB sites to carry out its role in DNA-end resection. p53 has 
also been shown to interact with hnRNP-UL1 through pull-down and co-immunoprecipitation 
assays [7]. The co-immunoprecipitation of hnRNP-UL1 with CtIP in [4] did not necessarily 
mean the two species directly interact with one another. Like hnRNP-UL1, CtIP had been 
shown to directly bind the NBS1 subunit of MRN and co-immunoprecipitation of hnRNP-
UL1 and CtIP could occur through these shared interactions with NBS1 [39]. Our study did 
confirm the in vitro interactions between hnRNP-UL1 and CtIP, as well as, with BLM and 
p53 through GST-pulldown experiments. The direct interaction of CtIP, BLM and p53 with 
hnRNP-UL2 was also shown, with p53 exhibiting two-fold better binding efficiency than 
CtIP and BLM. 
 The interaction of p53, CtIP and BLM was mapped to the middle and C-terminal 
portions of hnRNP-UL1, whilst an N-terminal fragment showed no interaction. A BBS-RGG 
domain fragment of hnRNP-UL1 was capable of strongly binding to p53. Whilst deletion of 
BBS and RGG independently highlighted their requirement for interaction with CtIP and 
BLM, the BBS-RGG domain fragment alone failed to show significant interaction with CtIP 
or BLM, however. This suggested interactions between CtIP and BLM with hnRNP-UL1 
respectively, appear to require extensive interactions across the BBS and RGG domains and 
beyond. Interactions within the PP domain also appeared to be of significance as its deletion 
perturbed interaction. The requirement of the BBS domain in the interaction with BLM is 
consistent with functional studies carried out in [4]. That study showed hnRNP-UL1 
depletion via siRNA treatment impaired BLM recruitment to sites of DNA resection during 
DNA repair. Whilst expression of a siRNA-resistant wild-type hnRNP-UL1 construct rescued 
recruitment, a ∆BBS mutant did not. Therefore, our in vitro studies confirmed the BBS 
region of hnRNP-UL1 to be required for the binding of BLM. 
 To extend the analysis of the BLM-hnRNP-UL1 binding, we then investigated which 
regions of BLM were required for hnRNP-UL1 interaction. Of the 4 GST-fragments of BLM, 
fragments 1 (N-terminal region, aa 1-212) and 4 (C-terminal region, aa 1001-1417) were able 
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to bind hnRNP-UL1 in vitro. The interactions of BLM and topoisomearases has been widely 
studied in the last 10 years and function together in a complex with RMI1 (RecQ-mediated 
genomic instability protein 1) to catalyze the dissolution of double Holliday junctions into 
noncrossover products, a process critical within DNA repair by HR [29]. The amino acids 
489-587 of BLM were found to directly interact with topoisomerase IIα [40]. Our results 
show, this is a different region of BLM that is required to interact with hnRNP-UL1. 
Deletions within the BBS-RGG domain of hnRNP-UL1 were shown to be critical in the 
binding of BLM and a fragment of the BBS-RGG domain was sufficient independently to 
bind fragment 1 of BLM. Interestingly, whilst deleting the BBS and RGG domains perturbed 
binding to fragment 4 significantly, the BBS-RGG domain on its own showed very limited 
binding to fragment 4. This may be due to the binding of fragment 4 requiring other sections 
of hnRNP-UL1 outside of the BBS-RGG domain. It may also be due to the small fragments 
of the proteins (BBS-RRG of hnRNP-UL1 and aa 1001-1417 of BLM) failing to adopt the 
correct secondary structure (as seen in the intact protein) and this may inhibit interaction even 
though much of the binding site is present. 
 Previous studies showed that depletion of either hnRNP-UL1 or -UL2 caused defects 
in DNA-end resection during DSB repair, showing they are not redundant in their actions 
despite sharing considerable amino acid sequence homology (Figure 3.2) [4]. Their 
recruitment to DSB sites was also shown to be largely interdependent, suggesting that they 
are recruited as a complex. Our studies were able to confirm the direct binding of the hnRNP-
U-like proteins to one another. hnRNP-UL1 was shown to homo-dimerize with itself and also 
hetero-dimerize with hnRNP-UL2. It appeared that the RGG domain was most critical for 
hnRNP-UL1’s interactions both with itself and with hnRNP-UL2. HnRNPs form complexes 
together during their mRNA processing activities and many studies have shown them to hom- 
and hetero-dimerize [6,36,37,38]. 
 
 All previous work within the study up to this point had been completed in vitro. 
Whilst confirming direct interaction between binding proteins, it did not address their 
interaction in vivo. Co-immunoprecipitation studies with cell lysates confirmed the in vivo 
association with p53, CtIP and BLM. It also interestingly revealed an interaction with poly 
(ADP-ribose) polymerase (PARP), a protein playing an essential role in the response to DNA 
damage [41]. PARP is rapidly recruited to sites of both double-strand and single-strand 
breaks and mediates poly(ADP-ribose) (PAR) modification of itself and histones. The 
poly(ADP-ribosyl)ation of histones mediates chromatin relaxation, which allows greater 
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accommodation of DNA repair factors at sites of damage [41]. PAR production also 
stimulates the recruitment of various DNA repair factors through their PAR-binding domains 
[42]. The discovery of the in vivo interaction between PARP and hnRNP-UL1 and hnRNP-
UL2 came late within this study and further investigation was not possible. However, their 
interaction adds another level to the complexity of hnRNP-U-like proteins within the DDR. 
 As discussed above many previous studies had revealed hnRNPs to interact with one 
another in complexes. Indeed, within this study the two hnRNP-U-like proteins had been 
shown to hetero-dimerize and hnRNP-UL1 to homodimerize. In vivo interactions were 
confirmed between hnRNP-H, -K and –U and the hnRNP-U-like proteins, and the BBS-RGG 
domain of hnRNP-UL1 was sufficient for interaction with hnRNP-H and –U alone. 
 Towards the end of the study mass spectrometry was employed to highlight possible 
interacting partners for hnRNP-UL1 by analysing the GST-pulldown samples carried out 
with the BBS-RGG fragment. The results confirmed interacting partners already identified 
such as hnRNP-UL1, hnRNP -UL-2 and hnRNP –U. Other hnRNPs (hnRNP-D0, -R and –
A/B) were also found. Further proteins identified with potential roles in the DDR were DNA-
damage-binding protein 1, ATM, E3 ubiquitin-ligase SHPRH, E3 ubiquitin-protein ligase 
TTC3 and E3 ubiquitin-protein ligase BRE1A. It should be stressed, however, that such 
interactions are tentative and require confirmation through further work. For example, 
hnRNPs are very well known to occur in mass spectrometry analyses through non-specific 
interactions.  
 In conclusion, this study has confirmed the protein-protein interactions of various 
other studies which reveal a link between hnRNP-U-like proteins and the DNA damage 
response. The results have extended our knowledge of these interactions in terms of the 
distinct regions of the proteins required for binding, and PARP has also been identified as a 
novel interacting partner of hnRNP-UL1 and –UL2.  
 
4.1 Limitations 
The short duration of the study was a limiting factor to how far the study could go. Repeats of 
the GST-pulldown experiments conducted with in vitro translated proteins used for 
densitometric analysis in Figures 3.1, 3.2c and 3.3 would improve their reliability and the 
conclusions drawn from them. Similarly, it would be essential to repeat the mass 
spectrometry analysis. To explore the interaction with PARP would have been of great 
interest, however, this interaction was observed towards the end of the study and further 
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experiments were not possible. Antibodies against some of the hnRNPs were of poor quality 
and made confirming interactions between hnRNPs through GST-pulldown and co-
immunoprecipitation assays difficult. 
 
4.2 Future Work 
As the binding site for hnRNP-UL1 on BLM was mapped using 4 GST-BLM fragments in 
GST-pulldowns with in vitro translated hnRNP-UL1 fragments, the same could be completed 
with CtIP employing the use of GST-CtIP fragments. In the long term, investigations in to the 
functionality of hnRNP-UL1 with the various mutated forms could be performed by knocking 
down endogenous hnRNP-UL1 and transfecting back the various fragments. Affects on the 
DDR could then be assessed via various methods. 
It would also be of great interest to carry out further investigation of the interaction 
between hnRNP-UL1 and PARP. Acquiring a GST-labelled version of PARP to explore its 
interaction with hnRNP-UL1 through GST-pulldowns with the in vitro translated deletion 
variants and fragments of hnRNP-UL1 would be of great interest. Would the BBS-RGG 
domain be critical to their interaction, as it was with p53, CtIP and BLM? To investigate if 
the interaction was significant to the correct execution of the DDR would also be of great 
interest. DNA damage could be induced within cells (e.g. through ionizing irradiation, ultra-
violet radiation or treatment with camptothecin) and the levels of hnRNP-UL1 and PARP 
interaction monitored at various time points by co-immunoprecipitation studies. This would 
give an indication to whether these proteins’ interactions are increased or decreased during 
DNA damage response and if so this would suggest a role in the DDR. It would also be of 
interest to examine whether hnRNP-UL1 and -UL2 affect the enzymatic activity of PARP in 
both in vitro assays and in vivo (by looking at the PARylation of proteins in cells with 
hnRNP-UL1 and –UL2 knocked down). Finally, further investigation of some of the proteins 
pulled down with the GST-hnRNP-BBS-RGG fragment and identified by mass spectrometry 
could be made. 
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Abstract 
The highly dynamic, post-translational protein modification, SUMOylation, has been 
identified as playing a key role in the DNA damage response (DDR). Given the highly 
reversible and dynamic nature of this modification it would appear logical that the 
deSUMOylation enzymes, SENPs (sentrin-specific proteases), would be critical for the 
correct execution of the DDR. Indeed, studies are now highlighting the requirement of 
SENPs within DNA repair mechanisms. Previous work in our laboratory had shown SENP7 
to be recruited to sites of DNA repair and identified SENP7 as an essential factor for 
homologous recombination (HR).  
 To cleave poly-SUMO-2/3 chains as SENP7 is known to do, it was expected that the 
protein would employ SUMO-interaction motifs (SIMs) to bind SUMO. Analysis of the 
primary structure identified 7 potential SIMs within SENP7. Mutation of all or various 
combinations of these SIMs did not perturb localisation of SENP7 to regions of 
heterochromatin within the cell nucleus. Meanwhile, the SIMs were shown to be of critical 
importance both for interaction with SUMO-2-modified proteins and the functionality of the 
protein within its role in homologous recombination (HR). Of these 7 potential SIMs, those 
numbered 6 and 7 in this study were shown to be of greater importance than that of the other 
SIMs for SENP7 functionality. A clear correlation was also identified between the number of 
potential functional SIMs and the HR capability of the cells. However, this did not strictly 
correlate with the SUMO-binding capabilities of the SIMs, suggesting that SIMs 6 and 7 may 
deliver bound SUMO chains to the catalytic site of SENP7 more efficiently than others. 
During co-immunoprecipitation studies, KAP-1 (TIF1-β – transcription intermediary factor 
1- β) was shown to interact with SENP7 and could be a potential substrate for 
deSUMOylation. 
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1.1 Introduction 
 Many proteins are modified post-transcriptionally by various methods, including 
phosphorylation, acetylation, methylation and protein-based modification. Ubiquitination was 
the first protein-based modification to be described and in recent years many others have 
been discovered. SUMO (small ubiquitin-like modifier) as the name suggests is an ubiquitin-
like protein (UBL) and can be covalently attached to target proteins to modify their dynamics 
and functions. Both modifiers, ubiquitin and SUMO, are typically attached to lysine residues 
of target proteins and can also be conjugated as monomers or as polymeric chains [43]. Like 
ubiquitylation before it, SUMOylation has emerged as a critical regulator of proteins 
involved in many biological processes, including the DNA damage response (DDR), which is 
of particular interest to our group [44]. 
1.2 SUMO and the SUMOylation Pathway 
 Three isoforms of SUMO are known to be conjugated to target proteins, SUMO-1, -2  
and -3. The matured SUMO-2 and SUMO-3 differ by just 4 amino acids (~97% identical) 
and are roughly 50% identical in sequence to SUMO-1 [44]. Target proteins are SUMOylated 
via a sequential enzymatic process involving an activating enzyme (E1), a conjugating 
enzyme (E2) and a SUMO protein ligase (E3) [45]. Firstly, a heterodimer of SUMO-
activating enzymes, SAE1 and SAE2, employs ATP to adenylate the C-terminal glycine of 
SUMO. The second reaction involves the transfer of SUMO from the E1 enzyme to a 
cysteine residue within the E2-conjugating enzyme, Ubc9 (ubiquitin-conjugating enzyme 9). 
The Ubc9-SUMO conjugate then catalyses the formation of an isopeptide linkage between 
the C-terminal carboxyl group of SUMO and the ε-amino group of a lysine residue within the 
substrate (Figure 1.2). This lysine residue most commonly lies within a consensus motif 
ψKX(D/E), (where ψ is a large hydrophobic amino acid and X is any amino acid), however, 
modification has been found to occur at non-consensus sites [46]. Ubc9 does have the 
capability to carry out the addition of SUMO to its target on its own, however, E3 ligases are 
commonly employed and appear to provide substrate specificity and enhance reaction 
efficiency [45]. 
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Figure 1.2 – The SUMO Pathway. Specific SENPs (sentrin-specific proteases) are first 
required to process specific precursor forms of SUMO (1), before they are activated by Sae1 
and Sae2. SUMO is then conjugated to the E2, Ubc9 (3), which along with an E3 ligase 
recognises a specific target protein (4) and catalyses SUMO conjugation (5). SENPs are then 
also required for deSUMOylation of target proteins (6) (Adapted from [13]). 
 
SUMO-2 and SUMO-3 have the capability to form polymeric chains through a 
conserved lysine (K11) embedded within a typical consensus modification site. SUMO-1 
does not have such a capability, but it has been reported to be linked to the end of a poly-
SUMO-2/3 chain causing termination of chain growth [47]. SUMOylation of target proteins 
is reversible and often an extremely dynamic process with SUMO modifications being made 
and removed in quick succession [48]. SUMOylation is regulated in part by their target, 
SUMO-modified proteins, which contain ψKX(D/E) consensus motifs enabling direct 
interaction with Ubc9. Thus, the target for SUMOylation plays an essential role in the 
stability of the interaction between the E2 enzyme and the substrate [44]. DeSUMOylation is 
carried out by a family of cysteine proteases called SENPs (SUMO-1/sentrin/SMT3-specific 
peptidases), which is discussed in greater detail in section 1.4 [45]. 
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1.3 SUMO-Interaction Motifs (SIMs) 
SUMOylation of proteins can regulate their protein-protein interactions. This is largely due to 
the presence of SUMO-interaction motifs (SIMs), most typically characterised by a short 
stretch of hydrophobic amino acids [(V/I)X(V/I)(V/I)] flanked by acidic residues, which 
show specificity for SUMO. When complexed to SUMO, the SIM adopts a parallel or 
antiparallel β-strand conformation, which allows the hydrophobic pocket of the SUMO 
surface to interact with the hydrophobic side chains of the SIM [49,50]. It has been 
hypothesised that the flanking acidic residues of the SIM can form salt bridges or hydrogen 
bonding interactions with the conserved basic residues on the SUMO surface and in doing so 
help determine the polarity of a SIM-SUMO interaction [44]. SIMs have been discovered in a 
wide range of proteins, including SUMO enzymes, SUMO substrates, SUMO-binding 
proteins and SUMO-targeted ubiquitin ligases [44]. Some examples include the base excision 
repair enzyme thymine DNA glycosylase (TDG), promyelocytic leukemia protein (PML) and 
the transcription factor DAXX [51,52]. The SIMs within the above mentioned proteins do not 
appear to confer specificity for a particular SUMO isoform, however, this is not always the 
case as seen with ubiquitin-specific protease 25 (USP25), which exhibits a preference for 
modification by SUMO-2/3 [53]. Whilst it appears that the architecture of a SIM can 
determine SUMO-interaction specificity the molecular determinants that underlie this 
specificity are yet to be eluded [44]. 
1.4 SENPs (SUMO-1/Sentrin/SMT3-Specific Peptidases) 
There are six SENPs in humans (SENP1-3 and SENP5-7), which show sequence homology 
to two proteins executing similar roles in yeast cells (Ulp1 and Ulp2). Localisation of the 
human SENPs within the cell differs; SENP-2 is localised to the nuclear core complex, 
SENP-1, -6, and -7 are localised to the nucleoplasm, and SENP-3 and -5 to the nucleolus. 
SENPs fulfil two essential functions: the processing of precursor SUMO to its mature form 
(C-terminal hydrolase activity) and of interest to this study, the cleavage of isopeptide bonds 
between SUMO and its target protein (isopeptidase activity) [45]. 
 SENP1 and SENP2 both exhibit greater isopeptidase activity than hydrolase activity 
with SENP1 removing SUMO-1 and SUMO-2/3 conjugates with equal efficiency from target 
proteins. SENP2, however, has shown a preference for deconjugation of SUMO-2/3 from 
target proteins. Studies have also revealed SENP3 and SENP5 to have greater isopeptidase 
activity on SUMO-2/3-conjugated targets than SUMO-1-modified species. Meanwhile, 
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SENP6 and SENP7 have repeatedly shown a preference for deconjugating poly-SUMO-2/3 
chains over singularly-attached SUMO moieties (Figure 1.4) [54,55].  
 
 
Figure 1.4 – The Varying Isopeptidase Activities of the Various SENPs within the 
SUMO Pathway. E1, E2 and E3 enzymes are required for the SUMOylation of substrates 
and synthesis of poly-SUMO chains. Whilst SENPs 1,2, 3, and 5 are responsible for 
deSUMOylation of mono-SUMOylated substrates, SENPs 6 and 7 have shown specificity for 
deconjugating poly-SUMO chains. 
 
1.5 The DNA Damage Response (DDR) 
Cells have hugely complex mechanisms to deal with the continuous damage the DNA 
undergoes from both exogenous and endogenous sources, which can result in single-strand 
lesions, double-strand breaks and inter-strand crosslinks. Critical regulators of DNA damage 
response (DDR) pathways are the PI3K (phosphatidylinositol 3 kinase) proteins, ATM 
(ataxia telangiectasia) and ATR (ataxia telangiectasia and RAD3 related) proteins, and their 
activation can trigger activities such as cell cycle inhibition, DNA repair or even apoptosis. 
ATM is activated in response to double-stranded DNA breaks (DSBs) commonly caused by 
ionising radiation (IR), cellular stress and prolonged stalling of replication forks. Meanwhile 
ATR is activated in response to single-stranded DNA lesions induced by ultra-violet (UV) 
radiation [10]. 
 Of focus to this investigation is the repair of double-strand breaks (DSBs). DSBs are 
commonly repaired via two mechanisms; homologous recombination (HR) and non-
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homologous end joining (NHEJ). The cells choice of repair mechanism is dependent upon the 
stage of the cell cycle as HR requires a section of homologous DNA in order to complete 
error-free repair. However, the sister chromatids required for such repair are only available 
during the S and G2 phases of the cycle. During other phases of the cell cycle NHEJ must be 
employed which is error-prone meaning the DNA sequence is often altered during repair 
[12]. 
To repair a DSB by HR, a cascade of tightly controlled protein signalling must be 
achieved to firstly recognise the DNA break, recruit repair factors and then execute accurate 
repair. The following details just a few of the main players within the initial response to a 
DSB by HR to create a distinct focal point around the location of the break, often referred to 
as Ionizing Radiation-Induced Foci (IRIF) [13]. The MRN complex is able to sense DSBs 
and is able to stimulate ATM, which activates itself by autophosphorylation at S1981 [14]. 
These proteins are recruited to DSB sites and ATM is able to phosphorylate a large number 
of proteins contributing to cell-cycle arrest, DNA repair and apoptosis (Figure 1.5). One such 
protein is the histone H2AX, whose phosphorylation mediates interaction with the scaffold 
protein MDC1. MDC1 acts as a hub for many proteins involved in the DDR to attach and 
form repair foci, including the ubiquitin ligases RNF8, RNF168 and BRCA1.  As detailed in 
Figure 1.5, the ubiquitylation of histones H2A and H2AX, as well as other substrates, by 
ubiquitin ligases is critical for recruitment and correct function of proteins within the DDR to 
DSBs [15]. In recent years, SUMOylation within the DDR has been increasingly recognised 
as crucial for controlled regulation and correct execution of DSB repair. 
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Figure 1.5 – The Early Responses to DSBs Resulting in the Highly Hierarchical 
Assembly of IRIF. The DSB is sensed by the MRN (MRE11-RAD50-NBS1) complex, 
which recruits the ATM kinase (A) resulting in turn in the recruitment of the scaffold protein 
MDC1 via phosphorylation of the histone H2AX. MDC1 recruits many proteins including the 
ubiquitin ligase RNF8, which ubiquitylates histones (C) to further recruit a second wave of 
repair factors such as 53BP1, the BRCA1 A complex and so on. The assembly of these repair 
proteins controls various DNA and chromatin transactions, ultimately leading to repair of the 
DSB. P: phosphate, M: MRE11, N: NBS1, R: RAD50, Ub: Ubiquitin, A: Abraxas (ABRA1), 
80: Rap80, EXP1: EXPAND1 [16]. 
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1.6 Ubiquitylation and SUMOylation in the DDR 
The cascade of DDR signalling described above involves the timely and spatially specific 
assembly and disassembly of large protein complexes, which must be stringently controlled 
[43]. The specific orchestration of their localisation, interactions, activities and so on, is 
hugely aided by post-translational modifications. In recent years, modification by 
ubiquitylation has been revealed to be far from a simple marker for degradation, but instead a 
highly versatile modification with increasingly broader implications. The popularity of the 
ubiquitylation and SUMOylation stories has led to much increased study and it appears they 
have roles in many nuclear functions, including DNA repair mechanisms and checkpoint 
responses [56]. Given the highly reversible and dynamic nature of the two modifications it is 
unsurprising that they appear to be of such critical importance to the DDR as it is such a 
complex and highly regulated process. It also seems logical that the de-SUMOylation 
enzymes, SENPs, would be of critical importance to the correct execution of the DDR, as will 
be briefly explored within this study with regards to SENP7. 
 Several examples of the importance of ubiquitylation and SUMOylation 
modifications within the DDR have been shown in recent years.  As touched on earlier, the 
ubiquitin ligases RNF8 and RNF168 form lysine (K) 63-linked chains, which act to anchor 
the adaptor protein RAP80 through its ubiquitin-interaction motif (UIM) domain, and RAP80 
in turn recruits BRCA1 to repair foci [15]. PIAS1 and PIAS4 are E3 SUMO ligases required 
for promotion of BRCA1 accumulation at sites of repair, as well as, stimulate SUMOylation 
of BRCA1, which is crucial for its own ubiquitin-ligase activity. Cells also exhibit increased 
sensitivity to DNA damaging agents and fail to carry out efficient HR and NHEJ when 
PIAS1 and PIAS4 expression is depleted [57,58]. This suggests a cross-link between 
SUMOylation and ubiquitylation in DNA repair pathways. 
 SUMO/Ub cross-talk within the DDR is perhaps no more evidently displayed than in 
the modification of the proliferating cell nuclear antigen (PCNA) at the evolutionary 
conserved lysine 164 [59]. PCNA ubiquitylation is induced by DNA damage and required for 
DNA repair. Mono-ubiquitylation facilitates tranlesion DNA synthesis (TLS) via mediating 
interaction with TLS polymerases through their UIMs. However, K-63 linked poly-
ubiquitylation directs repair through HR [60]. SUMOylation of PCNA on the other hand, 
inhibits repair by recombination through recruitment of the SIM-containing protein, Srs2 
[61]. 
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1.7 SENPs (Sentrin-Specific Proteases) in the DDR 
RPA70 is the major ssDNA-binding subunit of the replication protein A (RPA) complex, 
which plays a critical role in the DDR. RAP70 associates with SENP6 during the S phase of 
the cell cycle to maintain RPA70 in a hypo-SUMOylated state [62]. However, in times of 
induced replication stress, the two proteins dissociate allowing SUMOylation of RPA70 by 
SUMO-2/3. This initiates DNA repair through HR via recruitment of Rad51 to the repair foci. 
Consistent with these results, γ-H2AX, RPA, and Rad51 foci are unperturbed by SENP6 
knockdown, suggesting a role downstream of the early responses to DNA damage [62]. With 
regard to mammalian cells this is the only published work currently showing a direct link 
between SENPs and the DDR. However, work in yeast with Ulp2 (the yeast homolog to 
SENP 6 and 7) also showed a requirement in the later stages of the DDR and possible 
involvement in the restart of the cell cycle following termination of the DNA damage 
checkpoint [63]. 
 Previous work in our laboratory had shown knockdown of SENP6 and SENP7 to 
cause large defects in HR repair capability. This could be conceived to be due to a loss of 
availability of SUMO-2/3 in the cell as deSUMOylation of poly-SUMO-2/3 chains is not 
possible in their absence. Indeed, unpublished work within our laboratory showed over-
expression of RFP-SUMO rescued HR in SENP6-depleted cells, however, it did not do so in 
SENP7-depleted cells suggesting a more direct role in HR. 
 Further work upon SENP7 showed it to be recruited to sites of DSBs and co-localise 
with γ-H2AX in response to damage mediated by hydroxyurea. SENP7 was found to be 
chromatin bound through its interaction with heterochromatin protein-1-α (HP1-α) [64]. A 
HP1 box comprising of 7 amino acids (I,P,R,V,I,L,T) mediated interaction with HP1-α, and 
mutation of this domain disrupted binding and localisation of SENP7 to chromatin. Depletion 
of SENP7 was also found to reduce poly-Ub chain enrichment at sites of damage, as well as, 
disrupting Rad51 kinetics. 
 
1.8 SENP7 and its SUMO-Interaction Motifs 
A large part of this project was to look at the SUMO interaction properties of SENP7. Whilst 
SIM:SUMO interactions are known to be critical in the conjugating of SUMO to its targets, it 
is not known if they are involved in deconjugation. By studying the amino acid sequence of 
SENP7 and looking for the SIM consensus of amino acids [(V/I)X(V/I)(V/I)], 10 potential 
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SIMs were identified (Figure 1.8a). Three of these potential SIMs fell within the N-terminal 
catalytic domain and due to knowledge of the crystal structure of the domain it appeared that 
these were very unlikely to be of importance as they were located within well-formed 
secondary structures [55]. 
 
Figure 1.8a – Schematic of the SENP7 Protein. Red lines indicate the 10 SIMs identified 
within the coding sequence of SENP7. The c48 peptidase (catalytic domain) is also indicated. 
The numbers above represent amino acid number. 
 
Crystallographic studies and computational modelling studies have shown SENP7 and 
SENP6 to have greater structural similarities to one another, whilst exhibiting significant 
differences to the other members of the SENP family [55]. These changes are likely to play a 
role in their preference for poly-SUMO-2/3 chains. Indeed, the identification of four 
sequence insertions (Loop-1 through to Loop-4) within SENP6 and SENP7 are thought to 
permit greater interaction with SUMO chains which have more flexible isopeptide linked 
substrates [55]. 
Another protein found to preferentially bind poly-SUMO-2/3 chains is the SUMO-
targeted ubiquitin ligase, Ringer finger protein 4 (RNF4). This preferentiality has been shown 
to be due to a set of tandem SIMs that can recognise two or more SUMO-2/3 molecules in a 
chain [65]. SENP7’s 7 potential SIMs (outside of the catalytic domain) may also be critical 
for its poly-SUMO-2/3 specificity [55]. However, the SIMs do not appear in tandem (Figure 
1.8a) and it is unclear which of the SIMs are critical for SUMO binding. Figure 1.8b shows 
the amino acid sequences of the 7 potential SIMs of SENP7. To test their importance in 
SUMO interaction a construct of SENP7 was synthesised with these 7 potential SIMs made 
dysfunctional by changing their 4 amino acid SIM consensus (Figure 1.8c). This created a 
SIMless mutant of SENP7 to work with within the study. 
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SIM-6
SIM-7
 
Figure 1.8b – The 7 Potential SIMs of SENP7. Numbered 1 to 7 in the order in which they 
appear in the primary sequence of the protein’s amino acids. The 4 amino acids making up 
the recognised SIM sequence [(V/I)X(V/I)(V/I)] is boxed. 
 
 
S
IM
 1
WT
SIMless
GTC ATC TCT CTA
V        I       S      L
A       A S      L
GCC GCC TCT CTA S
IM
 2
WT
SIMless
ATT TCT CTT TTA
I        S       L      L
I        S       A      A
ATT TCT GCT GCA
S
IM
 3
WT
SIMless
CTC ACT CTG ATT
L       T       L       I
L       T       A      A
CTC ACT GCG GCT S
IM
 4
WT
SIMless
ATT GAT ATT GTG
I        D       I       V
I        D       A      A
ATT GAT GCT GCG
S
IM
 5
WT
SIMless
ATT CTT AAG TTA
I        L       K      L
A       A K       L
GCT GCT AAG TTA S
IM
 6
WT
SIMless
ATT TCA TTG CTA
I       S       L      L
I       S       A      A
ATT TCA GCG GCA
S
IM
 7
WT
SIMless
ATA AGT ATA ATC
I        S       I        I
I       S       A      A
ATA AGT GCA GCC
 
Figure 1.8c – The 7 Potential SIMs of SENP7 shown in their Wild-Type (WT) and 
SIMless Forms. The DNA sequence triplet codes and the amino acid sequences they encode 
are shown for WT SENP7 and SIMless SENP7 for each potential SIM. The nucleotide 
changes required to alter the translated amino acid sequence are shown in red, as are the 
changes to the amino acid sequence.  
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1.9 Aims  
Based upon the studies and previous work conducted within the Morris laboratory discussed 
above and knowledge of SENP7’s SUMO-binding activity and primary structure (i.e. the 7 
potential SIMs), the principle aims of this study were outlined as the following: 
1. To investigate which of the potential SIMs within SENP7 have SUMO-binding 
activity. 
2. To investigate the importance of the potential SENP7 SIMs in homologous 
recombination (HR) and therefore, assess their importance for functionality of the 
protein.  
3. To address whether SIM:SUMO binding and HR activity show correlation to one 
another. 
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2. Materials and Methods 
 
2.1 Tissue Culture Techniques 
 
2.1.1 Maintenance of Human Cell Lines 
Cell lines were maintained in a 5% CO2 incubator at 37ºC (Table 2.1). Cell lines were 
sustained in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma), supplemented with 7% 
v/v foetal calf serum (FCS) (PAA Laboratories) and penicillin (+100 units/ml)/streptomycin 
(+100µg/ml) (Life Technologies). 
FlpIn cells, and the stable cell lines created from the FlpIn cell line (see section 2.2.3) 
used for inducible expression of various Flag-SENP7 constructs, were maintained in 
tetracycline-free DMEM.  
 
Table 2.1 Human Cell Lines Used in the Study. 
Cell line ATCC number Additional Information 
U20S HTB-96 Human epithelial osteosarcoma cell line (origin = 
bone). 
DR3 (Hela) CCL-2 (Parent 
cell line) 
Human epithelial adenocarcinoma cell line (origin 
= cervix). Contains human papilloma virus. 
293T CRL-11268 Human epithelial kidney cell line (origin = kidney). 
FlpIn-TREx-293 CRL-1573 
(Parent cell line) 
A tetracycline-regulated expression cell line stably 
expressing the tetracycline repressor. Transfection 
of the cell line with pcDNA5/TO FRT plasmid 
expression construct containing a gene of interest, 
allows selection with hygromycin and induction of 
expression with doxycycline. 
 
2.1.2 Human Cell Culture 
The passage of adherent cell lines was achieved by washing twice with PBS (phosphate 
buffered saline) (Sigma), trypsinisation using 5 mls of 1% trypsin-ethylenediaminetetraacetic 
acid (EDTA) (PAA Laboratories) and incubated at 37ºC until cells lost adherence to the 
tissue culture dish. 10 mls of media was added to deactivate the trypsin, followed by 
62 
 
centrifugation at 1,400 revolutions per minute (rpm) at room temperature for 4 minutes. The 
cell pellet was resuspended in media and re-plated at required density. 
 
2.1.3 Bacterial Cell Culture 
pcDNA3.1(-) E. Coli bacteria (α-select competent cells) (BioLine) were grown on LB agar 
plates (containing 10g/L Tryptone, 10g/L NaCl, 5g/L yeast extract, 15g/L agar, and 1.5g/L 
Tris/TrisHCl) (Fisher Scientific), supplemented with 100 ng/ml ampicillin or 50ng/ml 
kanamycin to select for those bacteria that had successfully been transformed with the vector 
of interest, and incubated at 37ºC overnight. When growth of the bacteria was required on a 
larger scale, colonies were placed in Luria broth (LB) (containing 10g/L Tryptone, 5g/L 
NaCl, 5g/L yeast extract, and 1.5g/L Tris/TrisHCl) (Fisher Scientific) and grown under 
agitation at 37ºC overnight.  
 
2.2 Cell Biology Techniques  
 
2.2.1 – Knockdown of Gene Expression using Small-Interfering RNAs (siRNAs) 
siRNA was prepared for transfection by adding to OptiMEM media (Gibco) and mixing with 
Dharmafect transfection reagent (Thermo Scientific) (1µl per well to be transfected) also in 
OptiMEM media (of an equal volume). The Dharmafect/OptiMEM solution was then added 
dropwise to the siRNA/OptiMEM solution and incubated for 30 minutes at RT. This was then 
added dropwise to the media covering the cells and the media swirled to ensure even 
coverage of the well. 
 
Table 2.2.1 siRNAs Used in this Study. The siRNAs used in this study are shown, along 
with siRNA type, sense sequence and source. 
Target protein siRNA Source 
Non-targeting Non-targeting siRNA #1 ThermoScientific 
SENP7 SENP7.2 Sigma 
 
2.2.2 – DNA Transfection of Human Cell Lines 
DNA was prepared for transfection by adding to OptiMEM media and mixing with Fugene 
transfection reagent (Promega) also in OptiMEM media (of an equal volume). The Fugene 
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and DNA solutions were vortexed thoroughly and allowed to incubate at RT for 30 minutes 
before adding drop-wise to media and gently swirling to ensure even coverage of the plate. 
 
2.2.3 – Creation of Stable Cell Lines, Selection with Hygromycin and Induction of 
Expression with Doxycycline 
FlpIn-TREx-293 cells were transfected with 2 µg of the pcDNA5/TO FRT plasmid DNA 
construct to be inserted and 1µg of the plasmid vector pOG44 was also used. This contains a 
sequence encoding the restriction enzyme, pOG44, required for recombination of the DNA 
construct in to the Frt site of the FlpIn cells. Stable cell lines were selected by treatment with 
200 µg/ml hygromycin B (Calciochem) and the induction of protein expression was made 
with 2µg/ml doxycycline (Sigma) supplementation of media. 
 
 
2.3 Protein Chemistry Techniques 
 
2.3.1 Harvesting Human Adherent Cells 
For harvesting cells for co-immunoprecipitation assays, media was removed and cells washed 
twice in cold 0.15M saline. Cells were incubated in 300mM nuclear buffer (10mM HEPES 
pH 7.6, 300mM NaCl, 1.5mM MgCl2, 10% glycerol, 0.2mM EDTA, and 0.1% Triton), 
supplemented with DNase (26.4 µg/ml) (Sigma), phosphatase inhibitor (X1) (Roche), 
protease cocktail inhibitor (X1) (Roche) and N-ethylmaleimide (NEM) (Sigma) at 4°C for 3 
minutes before pipetting the lysate in to Eppendorf tubes. Lysates were then incubated at 4ºC 
for 2 hours under gentle agitation. Lysates were subsequently centrifuged at 15,000 rpm for 
15 minutes and the pellet discarded.  
 
2.3.2 Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Proteins were separated according to molecular weight via SDS-PAGE. 10% polyacrylamide 
gels were made using the following components: 30% w/v acrylamide (37:5:1 BIS-
acrylamide) (Severn Biotech), 0.1M Tris (Melford)/ 0.1M Bicine (pH8.3) (Severn Biotech), 
0.1% SDS (Severn Biotech), 0.3% N, N, N’, N’-Tetramethylethylenediamine (TEMED) 
(Sigma), 0.6% ammonium persulphate (APS) (Sigma) and deionised water. Gels were cast in 
an assembled apparatus (BioRad) and wells filled with running buffer (0.025M Tris, 1.92M 
Glycine, and 0.1% w/v SDS) (GeneFlow). Cell lysate and co-immunoprecipitation samples 
were prepared for running on polyacrylamide gels by adding an equal amount of Laemmli 
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sample buffer (25% v/v glycerol (BDH Laboratories), 5% β-mercaptoethanol, 2% w/v SDS, 
0.01% w/v bromophenol blue (BDH Laboratories) and 65nM Tris (pH 6.8)). Samples were 
then heated at 95ºC for 5 minutes, spun down, and loaded in to the gel wells along with 
PageRuler Prestained Protein Ladder (Thermo Scientific). Gels were run at 150V typically 
for a time period of 80 to 110 minutes. 
 
2.3.3 Visualisation of Proteins on Nitrocellulose Membranes 
Proteins transferred from polyacrylamide gels on to polyvinylidene fluoride (PVDF) 
membranes (Millipore) were stained with Ponceau-S Stain (consisting of 0.1% w/v Ponceau-
S and 5% v/v acetic acid) (Sigma) for 30 seconds. Membranes were then thoroughly washed 
with deionised water for visualisation and then further washed in Phosphate-Buffered Saline 
Tween-20 (PBST) (containing PBS (Sigma) and 1% Tween-20 (Fisher Scientific)), to remove 
the remaining stain. 
 
2.3.4 Separation of DNA by Agarose Gel Electrophoresis 
5-7µl of sample DNA was added to 2-3µl of X5 GelPilot Loading Dye (Qiagen) before 
loading on to an agarose gel (consisiting of 0.8% w/v agarose (Sigma) and 0.0001% v/v 
ethidium bromide (Fisher Scientific), along with Hyper DNA ladder (Bioloine). Gels were 
typically run at 130V for 60-90 minutes, before visualisation via ultra-violet (UV) 
spectroscopy (Syngene G:BOX). 
 
 
2.4 Immunological Techniques 
 
2.4.1 Western Blotting 
Following molecular size separation of proteins by SDS-PAGE, proteins were transferred on 
to PVDF membrane via the following method. Transfer cassettes were assembled containing 
the following layers: a sponge, Whatmann 3MM blotting paper, PVDF membrane (firstly 
immersed in 100% methanol (ProLabo) to activate it prior to transfer), SDS-PAGE gel, 
Whatmann blotting paper and a sponge (all equipment was pre-immersed in transfer buffer 
containing 20% v/v methanol, 0.192M glycine and 0.025M Tris). The cassette was then 
placed in a transfer tank filled with transfer buffer and 100 volts run across it for 1 hour. 
Membranes were then blocked by placement in 5% skimmed dried milk (Marvel) in PBST 
for 30 minutes. Primary antibodies (Table 2.4.1a) were diluted in 5% skimmed dried milk in 
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PBST and incubated with the membranes for a suitable time period (typically overnight) at 
4ºC. The membranes were then washed 3 times for 15 minutes in PBST, before incubation 
with secondary antibodies (Table 2.4.1b) conjugated to horseradish peroxidise (HRP) in 5% 
skimmed dried milk in PBST for 2 hours at RT under gentle agitation. Membranes were 
washed again in PBST 6 times for 5 minutes each time, before being placed in enhanced 
chemiluminescence (ECL) reagent (consisting of 0.1M Tris-HCl pH 8.5, 1.25mM Luminol 
(Sigma), 0.81mM Coumaric acid (Sigma), 0.018% (w/v) hydrogen peroxide (Sigma)) and 
deionised water) for 1 minute and exposed to autoradiography film (Fujifilm) for a suitable 
time period. 
 
Table 2.4.1a – Primary Antibodies Used in this Study. Indicated are the primary antibodies 
used in this study, their antigens, dilution, use, species of origin and source. 
Antibody Antigen Dilution Use Species Company/Source 
Flag (M2) Flag 1 in 1000 WB, IP, 
Confocal 
microscopy 
Mouse  Sigma 
RFP RFP 1 in 1000 WB Rabbit Sigma 
KAP1 KAP1 1 in 1000 WB Goat Abcam 
Beta-actin Beta-actin 1 in 1000 WB Rabbit Abcam 
HP1-alpha HP1-alpha 1 in 1000 Confocal 
microscopy 
Rabbit Cell Signalling 
Technology 
(N.B. WB – Western blot; IP – immunoprecipitation) 
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Table 2.4.1b – Secondary Antibodies Used in this Study. Indicated are the secondary 
antibodies used in this study, their antigens, dilution, use, species of origin and source. 
Antibody Antigen Dilution Use Species Company/Source 
Mouse Mouse IgG 1 in 5000 WB Rabbit Dako Laboratories 
Rabbit Rabbit IgG 1 in 5000 WB Swine Dako Laboratories 
Goat Goat IgG 1 in 5000 WB Rabbit Dako Laboratories 
Mouse 
AlexaFlour-488 
Ab 
Mouse IgG 1 in 2000 Confocal 
microscopy 
Goat Invitrogen 
Rabbit 
AlexaFlour-555 
Ab 
Rabbit IgG 1 in 2000 Confocal 
microscopy 
Goat Invitrogen 
(N.B. WB – Western blot; IP – immunoprecipitation) 
 
2.4.2 – Co-Immunoprecipitation (Co-IP) 
293T cells were cotransfected with the various mutant SENP7 constructs and RFP as a 
control or with the RFP-SUMO-2 (Q90P mutant variant). When SUMO-conjugated proteins 
interact with Flag-SENP7 through SUMO interaction in which the Q90P variant of SUMO-2 
is involved, the interacting protein is not released from SENP7 as this mutant variant is not 
cleavable.  
Cell lysates, as prepared in Section 2.2.1, were incubated with 5-10µl (packed 
volume) of Anti-Flag (M2) Affinity Gel Beads (Sigma) on rotation at 4ºC overnight. Samples 
were then centrifuged at 3,000rpm, 4ºC for 1 minute and supernatant discarded. 1 ml of 
phosphate-buffered saline (PBS) (Sigma) was then added to the pellet, vortexed and spun 
again at 3,000rpm, 4ºC for 1 minute. This wash step was repeated a further 3 times. 
Supernatant was removed and 10µl Laemmli buffer (25% v/v glycerol (BDH Laboratories), 
5% β-mercaptoethanol, 2% w/v SDS, 0.01% w/v bromophenol blue (BDH Laboratories) and 
65mM Tris (pH 6.8))  added to the pellet. This is subsequently heated to 95ºC for 5 minutes 
and supernatent resolved by SDS-PAGE. 
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2.5 Molecular Biology Techniques 
 
2.5.1 – Polymerase Chain Reaction (PCR) 
The following reactants are added to a PCR tube: dNTPs (typically 0.2-0.4mM) (BioLine), 
the plasmid vector (a concentration typically of 0.02mM), the forward (F) primer and the 
reverse (R) primer (typically at concentrations of 0.3-0.5mM), and a DNA polymerase (Pfu 
enzyme (Sigma) or Pfusion polymerase (Promega) within a buffer (X10 buffer) (Promega). 
Suitable heat cycles for the required PCR were then undertaken. 
 
Table 2.5.1a – Primers Used in this Study. Indicated are the primers used in this study, the 
gene they target, their sequence and source. 
Gene being targeted Primer Sequence Source 
SENP7 SENP7 F ______ Sigma 
SENP7 158 F 5’-CTCAGAACGCTGGACTCTCC Sigma  
SENP7 545 F 5’-CCCACCTGTAACTGAGGGAAG Sigma 
SENP7 824 F 5’-TCATCTCGAACAGGAAAGCAG Sigma 
SENP7 1133 F 5’-GAGTAATGCCACCAAAAGTGC Sigma 
SENP7 1284 F 5’-AAGGGAACCAATCACTGATCTC Sigma 
SENP7 1492 F 5’-GCCCATATAATCCTGTCATGG Sigma 
SENP7 1700 F 5’-TAAAGCGGTTTGGGTTATGG Sigma 
SENP7 322 R 5’-CCGTCCATCGGACATTCGTC Sigma 
SENP7 790 R 5’-CCACTGTTAAGGTCTTCAGG Sigma 
SENP7 1025 R 5’-GGCTTTTCAAACTCAGTGG Sigma 
SENP7 1360 R 5’-CTGCTTGGTAACCCCCAG Sigma 
SENP7 1456 R 5’-TCAATGGTAGTTCTAACAATGCT Sigma 
SENP7 1690 R 5’-CAAACCGCTTTAAATGTGTGG Sigma 
SENP7 2050 R 5’-CAACACCAGCAGGGAAAG Sigma 
(N.B. F – forward primer; R – reverse primer) 
 
2.5.4 – Transformation 
Typically, 2-3µl of the plasmid DNA construct of interest was added to 50µl of competent 
pcDNA3.1(-) E. Coli bacteria and incubated on ice for 30 minutes. The cells were heat-
shocked for 45 seconds at 42ºC, placed back on ice for 5 minutes before adding 250µl of LB 
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broth under aseptic conditions and incubating at 37ºC for 1 hour. Cells were grown overnight 
on, a single colony picked and placed in to 400mls of LB and grown under gentle agitation at 
37ºC overnight. 
 
2.5.5 – Isolating DNA from Bacteria 
For maxi-preps, bacterial cell culture was centrifuged at 3,500rpm for 15 minutes at 4ºC and 
the supernatant discarded. For mini-preps, 1ml of bacterial cell culture grown overnight was 
placed in to a 1.5ml Eppendorf tube, centrifuged at 13,000rpm for 1 minute and the 
supernatant removed. A further 1ml of cell culture was added to the tube, spun again and 
supernantent discarded. Extractment of DNA from the bacterial cell pellet employed the use 
of the Machery-Nagel Nucleobond Xtra Maxi kit (maxi-prep) and the Machery-Nagel 
Plasmid DNA Purification kit (mini-prep). DNA was dissolved in sterile distilled water and 
concentration measured with the use of a Nanodrop spectroscopy machine. The DNA was 
stored at -20ºC until further required. 
 
2.5.6 – Sequencing of DNA 
The sequencing of DNA to confirm successful creation of various constructs was completed 
by an external source. DNA was prepared to a concentration of 100ng/µl and primers to a 
concentration of 3.2pmol/µl and outsourced to SourceBioscience (Lifesciences) for 
sequencing. 
 
2.5.7 – Preparation and Viewing of Samples by Confocal Microscopy 
U2OS cells were plated on to a 24-well plate in which small, circular, glass slides had been 
placed for the cells to adhere too. Cells were transfected with 1µg of DNA for each of the 
individual SENP7 construct plasmids used. After a period of 48 hours post-transfection, 
media was removed and the wells washed with 1ml of PBS. PBS was removed and cells 
fixed via incubation in 250µl of 4% w/v paraformaldehyde (PFA) (Sigma) for 10 minutes at 
RT. The 4% PFA was removed and cells incubated in 250µl 10% Triton (Fischer Chemicals) 
for 5 minutes at RT to allow cells to be permeable to antibodies. Triton was removed and the 
fixed cells left in PBS, covered in parafilm (Bemis) and left at 4°C until required for staining. 
 PBS was removed and the cells incubated for 24hrs with polyclonal rabbit anti-HP1-α 
Ab (1:1000) and for 1 hour with polyclonal mouse anti-Flag (M2) Ab (1:1000) within 200µl 
fetal calf serum (FCS) at 4°C. The FCS was removed and a four PBS washes made before 
subsequent incubation anti-rabbit 555 Ab (1:2000) and anti-mouse 488 Ab (1:2000) within 
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200µl FCS for 1 hour at 4°C. The FCS was once again removed and the cells washed two 
times in PBS, before addition of 0.4 µg/ml Hoescht stain (Sigma) in PBS for two minutes at 
RT. This was removed, the cells washed with PBS and the glass slides carefully removed 
from the wells and fixed cell-side-down upon a microslide via the use of Immunomount gel 
(Thermo Scientific). 
 Cells were examined using a Zeiss LSM 510 confocal microscope with three lasers 
giving excitation lines at 633, 543 and 488nm. Data from channels was collected with 8-fold 
averaging at a resolution of 1024x1024 pixels, using an optical slice of between 0.5 and 1mm 
using a 63x objective with the Zeiss Axioplan-II microscope. 
 
2.5.8 – Preparation of Samples for the Homlogous Recombiantion (HR) Assay and 
Analysis via Flourescent-Associated Cell Sorting (FACs) 
DR3 (Hela) cells were grown within 12-well plates. Endogenous SENP7 was knocked down 
via the use of a SENP7 specific siRNA (50nM per well) (SENP7.2) (Sigma). For control 
wells a non-targeting siRNA was employed (50nM per well) (Sigma). After 24 hours, media 
was removed and replaced with fresh media. Cells were subsequently cotransfected with 
various SENP7 mutant constructs, an RFP-encoding vector and a SceI recombinase-encoding 
vector (all at 1µg per well). The RFP expression of the cells is used to identify those cells 
who have been successfully transfected when analysing via FACs. The SceI recombinase-
encoding vector contains two inactive alleles of GFP (Figure 2.5.8). The first is inactive 
because within its coding sequence it contains the 18 base-pair (bp) restriction enzyme 
recognition site for the I-SceI recombinase. The second GFP allele is inactive due to 
truncation. SceI recombinase is a rare-cutting endonuclease derived from Saccharomyces 
cerevisiae and is therefore, very unlikely to cut the human genome. When the plasmid is 
transfected in to a cell and the SceI recombinase cleaves the first GFP allele a double-strand 
break (DSB) is created. Accurate repair of this DSB is only possible through HR by 
employing the second ‘donor’ GFP allele as a template for repair (as the cell uses the sister 
chromatid for HR during the S phase of the cell cycle). Once repaired, the cell expresses 
GFP. Therefore, the proportion of RFP positive cells exhibiting GFP expression during FACs 
analysis can be used to determine the HR capability of the cells. With reference to this study, 
the effect of the various SENP7 mutations upon the functionality of the proteins compared to 
WT SENP7 in terms of HR rescue can be assessed. 
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Figure 2.5.8 – HR Repair of GFP Allele After Cleavage by SceI. A schematic showing the 
repair of one GFP allele via employing a donor GFP allele during HR repair in response to a 
DSB after cleavage at a specific-site within the coding region of the first GFP allele. 
 
48 hours after cotransfection the media is removed, the cells washed with PBS and 
detached by trypsinisation. 1ml of PBS was then added and the cells transferred to FACs 
tubes. These are centrifuged at 1500rpm for 5minutes at 4°C and supernatant removed. 250µl 
of 4% w/v PFA is then added, the tubes vortexed to resuspend the cells and incubated at RT 
for 30 minutes under gentle agitation. The tubes are then spun again at 1500rpm for 5minutes 
at 4°C, supernatant removed and 250µl of PBS is added. Samples can be stored at 4°C until 
ready for analysis by FACs. Prior to analysis on an Accuri C6 Flow Cytometer cells are 
resuspended by vortexing. 
 
2.6 Statistical Methods 
2.6.1 Paired Two-Sided T-Test for Comparison of Means Derived From Small Samples 
T-tests were performed to evaluate the statistical significance between two groups of data for 
the HR assay. All t-tests were performed at a P-value of 0.05 using percentage points based 
on ‘student’s’ t-distribution. 
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3.1 – The Creation of Various SIM Mutant Versions of SENP7 
Employing the synthesised SIMless version of Flag-SENP7, various SIM mutants (Table 3.1) 
were created via two sets of PCRs. The first utilised primers specific for sequences either side 
of the SIM(s) of interest to create a PCR product of known size with either wild-type (WT) 
functional SIMs or mutated non-functional SIMs. For example, to create an intermediate 
section of DNA including the coding region for WT SIM1 a forward primer would be used 
that binds upstream of SIM1 on one strand and a reverse primer that binds downstream of 
SIM1 on the other strand whilst employing the Flag-WT-SENP7 vector (Figure 3.1a(A)). 
Alternatively, to create an intermediate section of DNA including the coding region for 
mutated SIMs 4 and 5 a forward primer would be used that binds upstream of SIM4 on one 
strand and a reverse primer that binds downstream of SIM5 on the other strand whilst 
employing the Flag-SIMless-SENP7 vector (Figure 3.1a(B)). Successful production of the 
intermediates from PCR1 was confirmed by agarose-gel electrophoresis allowing analysis of 
the intermediate sizes (Figure 3.1b). 
This ‘intermediate’ section of DNA was then used as the primers for a second PCR 
employing the reciprocal SENP7 vector (WT or SIMless) from the first PCR (details in Table 
3.1). Removal of methylated template DNA was achieved via enzymatic digestion with the 
restriction enzyme, Dpn1.Transformation in to competent bacteria and subsequent culture 
growth allows the purification of concentrated plasmid DNA containing the recombinant 
DNA of interest. Finally, sequencing of selected regions within the SIM mutant constructs 
confirmed their correct synthesis. 
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PCR1: Generates intermediates 
to be used as primers in PCR2.
PCR2: Site-directed mutagenesis 
PCR with intermediates on to 
SIMless-SENP7.
SIM 1-ONLY SENP7
A WT SENP7 VECTOR
SIMless SENP7 VECTOR
 
SIM 45m SENP7
WT SENP7 VECTOR
SIMless SENP7 VECTORB
PCR1: Generates intermediates 
to be used as primers in PCR2.
PCR2: Site-directed mutagenesis 
PCR with intermediates on to 
SIMless-SENP7.
 
Figure 3.1a – Schematic Highlighting the Steps Required to Produce the Various SIM 
Mutants of SENP7. A) The creation of a SIM 1-only mutant via the production of an 
intermediate section of wild-type (WT) SENP7 encompassing SIM 1 in its WT form. This is 
then used as a primer in a site-directed mutagenesis PCR with the SIMless SENP7 vector to 
produce the final vector carrying a Flag-SENP7 SIM 1-only recombinant section of DNA. B) 
The creation of a SIM 45-mutated mutant via the production of an intermediate section of 
SIMless SENP7 encompassing SIM 4 and SIM 5 in their mutated form. This is then used as a 
primer in a site-directed mutagenesis PCR with the WT SENP7 vector to produce the final 
vector carrying a Flag-SENP7 SIM 45-mutated recombinant section of DNA. 
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Table 3.1 – Details of the PCRs Required in Making the Various SIM Mutant 
Constructs of SENP7.  
Mutant 
SENP7 
construct 
Forward 
Primer  
Reverse 
Primer 
Size of 
intermediate 
piece of DNA 
Vector for 
PCR1 
Vector for 
PCR2 
Primer for 
sequencing 
SIM 1-O 158 F 322 R 164 WT SIMless SENP7 F 
SIM 23m 545 F 1025 R 480 SIMless WT 545 F 
SIM 45m 1133F 1456 R 326 SIMless WT 824 F 
SIM 45m 1492 F 2050 R 558 SIMless WT 1492 F 
SIM 23-O 545 F 1025 R 480 WT SIMless 545 F 
SIM 45-O 1133F 1456 R 326 WT SIMless 824 F 
SIM 67-O 1492 F 2050 R 558 WT SIMless 1492 F 
SIM 4567-O 
(i) 
158 F 1025 R 867 SIMless WT SENP7 F 
SIM 4567-O 
(ii) 
1133 F 2050 R 917 WT SIMless 824 F 
SIM 167-O 545 F 1456 R 911 SIMless WT 545 F 
SIM 123-O 
(i) 
1133 F 2050 R 917 SIMless WT SENP7 F 
SIM 123-O 
(ii) 
158 F 1025 R 867 WT SIMless SENP7 F 
SIM 2345-O 545 F 1456 R 911 WT SIMless 545 F 
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Figure 3.1b – PCR1 Produced Intermediates of the Expected Size for each of the 
Various SIM Mutants to be made. PCR product from PCR1 was subjected to ethidium 
bromide-supplemented agarose-gel electrophoresis and viewed via UV spectroscopy. 
 
3.2 – The Creation of Stable Cell Lines for Inducible Expression of Various SENP7 
Constructs 
It was realised that the creation of stable cell lines for the inducible production of Flag-tagged 
SENP7 protein of the WT, catalytic (CA), SIMless, and SIMless-catalytic (SIMlessCA) 
variants would be very useful for this study. WT and CA stables already existed in the 
laboratory, whilst the SIMless and SIMlessCA did not. Firstly, the SIMlessCA construct was 
made via site-directed mutagenesis of the SIMless vector to introduce a cysteine to alanine 
amino acid substitution at residue 992 (C992A) within the catalytic domain.  
 To create stable cell lines the section of recombinant DNA encoding the Flag-tagged 
SENP7 construct must be inserted in to the 5.1 kb inducible expression vector 
pcDNA5/FRT/TO. Over a period of weeks, stable cells were selected through hygromycin 
supplementation of media (see section 2.2.3 for further details). Treatment with doxycycline 
allowed the inducible expression of the protein encoded by the inserted gene, i.e. Flag-
SIMless SENP7 or Flag-SIMlessCA SENP7, and confirmed the successful creation of stable 
cell lines (Figure 3.2). 
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Figure 3.2 – Successful Creation of Stable Cell Lines for Inducible Production of Flag-SIMless 
SENP7 and Flag-SIMlessCA SENP7. A-B) Cell lines were induced or not induced with 2µg/ml 
doxycycline two days prior to taking cell lysates and subjecting to Western blotting. 
 
 
3.3 – The Cellular Localisation of SENP7 and HP1-α is Not Affected by the Various 
SENP7 Mutations 
SENP7 had previously been shown both in our own laboratory and in [64] to co-localise with 
HP1-α to heterochromatin within the cell nucleus. Confocal microscopy was employed to 
investigate whether any of the various mutated forms of SENP7 localise differently within 
the cell as compared to WT. It was shown that localisation is not effected within any of the 
mutants and co-localisation with HP1-α is unperturbed. This is somewhat expected as SENP7 
has been shown to interact with HP1-α through its HP1 box with no SIM involvement, as 
discussed in section 1.7. 
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Figure 3.3 – All the Various SENP7s Localise to the Nucleus. U2OS cells were transfected 
with 1µg of DNA for each SENP7 construct indicated. After 48 hours cells were fixed using 
4% paraformaldehyde (PFA) and treated with 10% Triton to allow cells to be permeable to 
antibodies. Cells were then incubated for 24hrs with polyclonal rabbit anti-HP1-α Ab 
(1:1000) and for 1 hour with polyclonal mouse anti-Flag (M2) Ab within fetal calf serum 
(FCS). Cells were then washed and incubated with anti-rabbit 555 Ab and anti-mouse 488 Ab 
within FCS. Cells were washed once again and stained with Hoechst for 2 minutes, before 
further washing, mounting on to microslides and viewing via confocal microscopy. 
 
 
3.4 – SENP7 Interacts with SUMO-2 and the Various Mutated Forms of SENP7 
Investigated in this Study Exhibit Different Strengths of Binding 
Many previous studies have shown SENP7 to interact with SUMO-2/3 preferentially over 
SUMO-1 [54,55]. Via immunoprecipitation methods, the various Flag-SENP7 proteins (WT 
and mutated) were isolated from cell lysates, along with any interacting partners. Through 
transfection of RFP and RFP-SUMO-2-Q90P (a catalytic resistant variant of SUMO-2 – see 
section 2.4.2 for details), when Western blotting, probing membranes for RFP allowed 
identification of any proteins with SUMO-2 modifications which interact with SENP7. Figure 
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3.4a shows that WT SENP7 interacted with SUMO-2 modified proteins, whilst the SIMless 
and SIMlessCA exhibited far less interaction, suggesting the SIMs are required for 
interaction with SUMO-2 moieties. Meanwhile, the CA SENP7 variant exhibited greater 
interaction with SUMO-2 moieties than WT. Whilst neither form of SENP7, CA or WT, can 
cleave the Q90P variant SUMO-2, it would be expected that poly-SUMO-2/3 chains existing 
in the cells at the time of cell lysis would consist of both of the Q90P variant SUMO-2 and 
also endogenous SUMO-2/3. WT SENP7 has the capability to cleave these residues releasing 
the attached SUMO-modified protein. However, the CA mutant does not have this capability 
and therefore, is expected to exhibit more interaction with SUMO-2-modified proteins. 
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Figure 3.4a - The Catalytic, SIMless and SIMless-Catalytic Mutants of SENP7 Exhibit 
Different Strengths of Interaction with SUMO-2/3 in Vitro Compared to WT. The 
various stable SENP7 cell lines were induced with 2µg/ml doxycycline and transfected with 
either RFP or RFP-SUMO-2/3 two days prior to making cell lysates. Note that uninduced 
WT SENP7 cells were transfected with RFP or RFP-SUMO-2/3 as a control. Lysates were 
then incubated with Flag(M2) Ab-coated beads for 24 hours at 4°C. A series of PBS washes 
were made, before addition of Laemmli buffer, heating at 95°C and subjecting to Western 
blotting.  
 
 Immunoprecipitation experiments to investigate the SUMO-2 binding capabilities of 
the various SIM mutant constructs revealed some interesting results. SIM 67-only, SIM 4567-
only, SIM 167-only, SIM-123-only and SIM 2345-only exhibited good binding to RFP-
SUMO-2 (Q90P). SIM 1-only surprisingly showed some binding also, however, the 
densitometry readings are a little skewed by smudges on the IP blot for RFP making 
interpretation difficult. Meanwhile, SIM 23-only and SIM 45-only exhibited little to no 
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interaction with RFP-SUMO-2 (Q90P) when compared to control (RFP-SUMO-2-Q90P 
only). 
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Figure 3.4b - The Various SIM Mutants of SENP7 Exhibit Different Strengths of 
Interaction with SUMO-2 in Vitro. 293T cells were cotransfected with the various SIM mutant 
constructs indicated and either RFP (A) or RFP-SUMO-2-Q90P (B) two days prior to making cell 
lysates. Transfection with RFP (A) or RFP-SUMO-2/3 (B) alone was used as a control. Lysates were 
then incubated with Flag(M2) Ab-coated beads for 24 hours at 4°C. A series of PBS washes were 
made, before addition of Laemmli buffer, heating at 95°C and subjecting to Western blotting. C) 
Densitometric scanning was used to quantify the proportion of RFP-SUMO-Q90P bound by 
the various SIM mutants relative to the amount of Flag-SENP7 immunoprecipitated. 
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Figure 3.4b continued - The Various SIM Mutants of SENP7 Exhibit Different 
Strengths of Interaction with SUMO-2 in Vitro. 293T cells were cotransfected with the 
various SIM mutant constructs indicated and either RFP (A) or RFP-SUMO-2-Q90P (B) two days 
prior to making cell lysates. Transfection with RFP (A) or RFP-SUMO-2/3 (B) alone was used as a 
control. Lysates were then incubated with Flag(M2) Ab-coated beads for 24 hours at 4°C. A series of 
PBS washes were made, before addition of Laemmli buffer, heating at 95°C and subjecting to 
Western blotting. C) Densitometric scanning was used to quantify the proportion of RFP-
SUMO-Q90P bound by the various SIM mutants relative to the amount of Flag-SENP7 
immunoprecipitated. 
 
3.5 – The Activity of the Various SENP7 Mutants Measured in Terms of the Cells 
Ability to Perform Homologous Recombination (HR) 
To investigate whether the SUMO binding efficiency of the various SENP7 mutants affects 
their function, the ability of the cells to perform homologous recombination (HR) was 
assessed (see section 2.5.8 for details). As expected, DR3 cells expressing endogenous 
SENP7 (treated with non-targeting siRNA and transfected with empty vector) were capable 
of carrying out HR close to the efficiency of those cells expressing WT Flag-SENP7 (treated 
with SENP7 siRNA and WT Flag-SENP7 vector transfected) (Figure 3.5a). In cells 
expressing no SENP7 (treated with SENP7 siRNA and only empty vector pcDNA5.0 
transfected) the percentage of HR relative to WT was less than 40%. In all other samples, 
endogenous SENP7 was knocked down and various mutants of SENP7 were transfected in. 
The CA, SIMless and SIMlessCA mutants failed to rescue the HR ability of the cells. 
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Figure 3.5a – Some SIM Mutants are able to Rescue the Cells Ability to Perform Repair of DSBs via Homologous Recombination 
Better than Others. DR3 (Hela) cells had their endogenous SENP7 knocked down via siRNA. Control cells were instead exposed to non-
targeting siRNA. After 24 hours the media was changed and the cells were cotransfected with the various SIM mutant constructs (or 
empty vector) as indicated, an RFP vector and a SceI recombinase encoding vector. After a further 48 hours, cells were harvested and 
fixed using 4% PFA. PFA was subsequently removed and cells resuspended in PBS, before analysis by fluorescent cell sorting (FACs). 
N.B. These results are representative of at least 3 separate experiments, each performed with 3 repeats for each sample. Error bars are 
shown for standard error. 
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Table 3.5 – SIM Mutants Statistical Difference to SIMless SENP7 in HR 
Capability. A paired, two-sided, Student’s t test was used to statistically analyse the 
change in HR capability of the cells when transfected with the various SIM mutants in 
comparison to SIMless SENP7. 
 
 
% HR rescue 
relative to WT 
SD df t value Statistical significance? 
(where P<0.05) 
SIM 1-O 50.8 14 4 1.93 No 
SIM 1m 83.0 10.7 4 6.20 Yes 
SIM 23-O 51.5 8.3 4 3.36 Yes 
SIM 23m 92 16.2 4 4.80 Yes 
SIM 45-O 56.9 10.9 4 3.18 Yes 
SIM 45m 51.1 14.4 4 1.91 No 
SIM 67-O 80.3 15.7 4 4.02 Yes 
SIM 67m 43.6 11.4 4 1.60 No 
SIM 123-O 55.9 9.4 5 3.77 Yes 
SIM 4567-O 74.1 16.9 4 3.30 Yes 
SIM 167-O 87.7 15.0 4 4.82 Yes 
SIM 2345-O 46.7 9.3 4 2.36 No 
SIM 4m 85.0 8.4 4 8.24 Yes 
SIM 5m 73.2 12.4 4 4.38 Yes 
 
No statistical difference was observed when comparing the average % HR 
rescue (relative to WT) of SIMless SENP7 to SIM 1-O, 45m, 67m and 2345-O (Table 
3.5). If the % of HR rescue observed with the SIMless construct of SENP7 is taken as 
non-rescuing, then it is possible to say that at the 5% level of significance from the 
Null hypothesis, the SIM mutants mentioned above are also non-rescuing. 
Meanwhile, the other SIM mutants indicated in Table 3.5 show some level of 
significant HR rescue in comparison to SIMless SENP7. The SIM mutants 1m, 23m, 
67-O, 167-O, 4m, and 5m show the highest t values (Table 3.5) and therefore greater 
degrees of significant difference from the non-rescuing SIMless. They are also shown 
to have the highest % HR rescue relative to WT SENP7 in Figure 3.5a. This 
statistically highlights some mutants as having greater HR capability than others. 
To identify if some of the potential SIMs appear to be more important for 
SENP7 functionality than others, the mutants have been paired in Figure 3.5a 
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according to the functional SIMs they possess in an attempt to make comparison 
easier. SIM 1-only has been shown to not rescue HR whilst SIM 1m rescues HR to 
over 80% of that of WT SENP7. As SIM 1 mutated still contains 6 functional SIMs 
this result was to be expected. Similar results are seen with the 23-O and 23m mutant, 
respectively. This suggests a possible hypothesis of the number of functional SIMs 
left within a mutant correlating to protein function and such a theory would appear 
logical. However, the trend does not continue with regards to the mutants 45-only and 
45-mutated, and also the 67-O and 67m. Neither 45-O or 45m rescued HR. 
Considering the 67-O mutant rescued HR to almost 80% of WT SENP7, it would be 
expected that the SIM 45mutated would be capable of such a level of rescue also, as it 
obviously contains two functional 6 and 7 SIMs. When comparing the rescue seen 
with the 67-O and 67m alone, it would be possible to argue that SIMs 6 and 7 seem 
particularly important for SENP7 function. This hypothesis also remains true when 
considering the high levels of rescue seen with 4567-O and 167-O. Their respective 
reciprocal SIM mutants, 123-O and 2345-O, do not exhibit significant levels of rescue 
and coincidently do not contain SIMs 6 and 7. The mutants 4m and 5m also show 
good levels of HR rescue relative to WT, both of which contain 6 functional SIMs out 
of 7, including numbers 6 and 7.  
As SENP7 has been shown to be preferential to binding to poly-SUMO-2/3 
chains it is conceivable and would appear logical, as mentioned above, that the greater 
the number of functional SIMs left within any SIM mutant the greater the ability to 
bind poly-SUMOylated proteins. To test this hypothesis the % HR rescue results for 
each SIM mutant containing the same number of functional SIMs as an average was 
plotted against the number of functional SIMs (Figure 3.5b). A relatively strong 
correlation can be seen between the number of functional SIMs and HR rescue. 
Whilst a clear correlation is visible, it is also clear that simply the number of 
functional SIMs remaining within SENP7 does not explain all the results seen. This is 
expected, as some SIMs may be of more importance for SUMO interaction and 
protein function than others, which has been eluded to already with SIMs 6 and 7. The 
greater importance of some SIMs over others can explain the relatively big standard 
error bars observed in Figure 3.5b. For example, whilst the 67m variant has 5 
functional SIMs out of 7 it does not rescue HR. This could be due to it missing the 
two SIMs which appear to be more crucial than any of the others and therefore, the 
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standard error bar seen for 5 functional SIMs is large and the average skewed below 
the trendline (Figure 3.5b). 
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Figure 3.5b – Averaged Results for the Number of Non-Mutated SIMs Present 
within SENP7 Correlates with Function of the Protein. A scatter graph plotting 
percentage of HR rescue relative to WT against the number of functional SIMs within 
the SENP7 construct (averaged results for all variants with the same number of 
variant SIMs). N.B. Error bars are shown for standard error. 
 
Using the densitometry readings from the IP showing the various SIM mutants 
interacting with SUMO2-Q90P, it is possible to investigate a relationship between 
strength of SUMO-binding and HR capability. The two variables do not appear to 
show correlation (Figure 3.5c). SIM mutants 4567-O, 67-O and 167-O show both 
good SUMO2-binding and HR rescue ability, whilst SIM mutants 123-O and 2345-O 
also exhibit good SUMO2-binding ability but their HR rescue capabilities are limited. 
Therefore, the story of SIM:SUMO interaction within SENP7 is probably a rather 
complex one. Whilst some trends have been observed in the results, no SIM can be 
defined as completely redundant or completely essential in SUMO binding or SENP7 
function. 
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Figure 3.5c – Binding Capability of the SIM Mutants to SUMO Does Not 
Correspond to HR Activity. A scatter graph plotting the binding capabilities of 
various SIM mutants (densitometry reading) versus the percentage of HR rescue 
relative to WT SENP7. (N.B. Note that SIM 1-O has not been included as its 
densitometry reading was falsified due to the smudging of the blot). 
 
3.6 – SENP7 Interacts with KAP-1 
KAP-1 (TIF1-β – transcription intermediary factor 1- β) coimmunoprecipitated with 
SENP7 (Figure 3.6). KAP-1 is known to be modified by SUMOylation and co-
localise with other numerous DNA damage response factors at DNA lesions [66,67]. 
KAP-1 is therefore very likely a substrate for deSUMOylation by SENP7. It also 
contains a HP1 box, like that of SENP7, and has been shown to interact with HP1-α 
[68]. Therefore, these 3 proteins probably interact as part of a complex. Across the 3 
repeat blots, WT showed little to no interaction with KAP-1, whilst CA and SIMless 
exhibited good interaction and SIMlessCA significantly less than these two. It should 
be noted that the inputs for the WT SENP7 extract are down in comparison to the 
other extracts which does make interpretation a little difficult. 
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Figure 3.6 – SENP7 Interacts with KAP1 in Vivo. The various stable SENP7 cell 
lines were induced with 2µg/ml doxycycline two days prior to making cell lysates. 
Regular untreated FlpIn cells were used as a control. Lysates were then incubated 
with Flag(M2) Ab-coated beads for 24 hours at 4°C. A series of PBS washes were 
made, before addition of Laemmli buffer, heating at 95°C and subjecting to Western 
blotting. 
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4. Discussion 
Previous work in this laboratory had shown both SENP6 and SENP7 to be required 
for efficient repair of DSBs by HR. The effects of knocking down SENP6 could be 
rescued by over-expression of RFP-SUMO suggesting it was a decrease in availability 
of SUMO due to lack of SENP6 that caused the HR defect. However, such rescue was 
not observed in SENP7-depleted cells, preluding to a more direct role for SENP7 in 
HR. In addition, it was found to be recruited to sites of DNA repair and co-localise 
with γ-H2AX in response to damage mediated by hydroxyurea. Other studies had 
shown SENP7 to preferentially cleave poly-SUMO-2/3 chains [54,55]. Therefore, it 
was expected that the protein would employ SUMO-interaction motifs (SIMs) to bind 
SUMO and analysis of primary structure identified 7 potential SIMs within SENP7 
outside of catalytic domain. 
 The creation of various SIM mutants allowed the investigation of which of the 
potential SIMs of SENP7 exhibited SUMO-binding activity and were required for 
efficient functionality of the protein. The methods of which are explained in section 
3.1 and the results were a series of Flag-tagged-SENP7 constructs with only a selected 
number of the 7 potential SIMs retaining function (Table 3.1).  
 Both in previous, unpublished work within our laboratory and within [64], 
SENP7 was shown to co-localise to heterochromatin within the nucleus through its 
interaction with HP1-α. The work presented in this study showed that none of the 
mutant variants of SENP7, including CA, SIMless, SIMlessCA and all of the SIM 
mutant variants, perturbed this co-localisation. This was expected as SENP7 was 
shown to bind HP1-α through a HP1 box domain with no relation to the SIMs of 
SENP7. With localisation of all the mutants confirmed to be the same as WT, the 
SUMO-binding and functionality of these proteins could be investigated in the 
knowledge that cellular localisation was not affecting the results.  
 Employing the use of a catalytic-resistant variant of SUMO-2 (RFP-SUMO-2-
Q90P), co-immunoprecipitation studies revealed the interaction of WT and CA 
SENP7 with SUMO-2 modified proteins. Critically important to this study was the 
observation that the SIMless and SIMlessCA mutants (devoid of all functional SIMs) 
exhibited a greatly significant decrease in interaction with SUMO-2 (Figure 3.4a). 
This confirmed the requirement of the SIMs for interaction with SUMO-2 modified 
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proteins. It was now possible to pursue an answer to the question: which of the 
potential SIMs possess SUMO-binding activity? 
 Further co-IP studies revealed that some SIM mutant variants bound to 
SUMO-2 modified proteins with greater efficiency than others. The mutants SIM 67-
only, SIM 4567-only, SIM 167-only, SIM 123-only and SIM 2345-only all exhibited 
good interaction with SUMO-2, whilst the mutants SIM 23-O and SIM 45-O did not 
(Figure 3.4b). It was now of interest to investigate if this binding capability of the 
SIM mutants correlated with the functionality of these proteins. This was assessed in 
terms of the cells ability in which these mutants were being expressed (with 
endogenous SENP7 knocked down) to carry out DSB DNA repair by HR. 
 As already known due to previous work completed in the laboratory, the CA 
and SIMless mutants were unable to perform HR to the levels of that of WT SENP7. 
These results were duplicated within this study and confirmed the requirement of 
SENP7 for effective execution of HR repair. SIMlessCA SENP7 produced similar 
results to that of the SIMless, as expected. Meanwhile, the various SIM mutants were 
shown to have varying levels of HR rescue relative to WT SENP7. Firstly, a clear 
trend could be seen in that all SIM mutants retaining functional SIMs 6 and 7 (SIM 
1m, SIM 23m, SIM 67-O, SIM 4567-O, SIM 167-O, SIM 4m and SIM 5m), with the 
exception of SIM 45m, rescued HR to above 73% relative to WT (Figure 3.5a). This 
highlighted these SIMs as of greater importance for protein function over the other 
SIMs. Whilst the SIM mutants above did show good levels of HR rescue, none 
rescued to the same level as that of WT, including those with just one SIM mutated. 
This highlights the fact that whilst SIMs 6 and 7 do appear to be of more importance 
for SENP7 function, they are not capable of fully rescuing the protein’s functionality 
on their own. The mutation of SIM 1, 4 or 5 alone also had an affect on HR 
capability, as none of these mutants rescued HR to the levels of WT, suggesting no 
single SIM is completely redundant. However, to make this conclusion definite, 
investigations would be needed with single SIM mutants for each individual SIM. 
 A correlation was also observed between the number of functional SIMs 
retained within the protein and HR capability (Figure 3.5b). This would appear logical 
when considering the known preference of SENP7 for binding to poly-SUMO-2/3 
chains [55]. Another protein found to preferentially bind poly-SUMO-2/3 chains is 
the SUMO-targeted ubiquitin ligase, Ringer finger protein 4 (RNF4). This 
preferentiality has been shown to be due to a set of tandem SIMs that can recognise 
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two or more SUMO-2/3 molecules in a chain [65]. SENP7’s 7 potential SIMs do not 
appear in tandem (Figure 1.8a), however, due to the known flexibility of the protein in 
the region of these SIMs their somewhat scattered location upon the primary structure 
of the protein may not be of importance. The results of this study do suggest that the 
more functional SIMs available to interact with the SUMOs of the chain the greater 
the strength of binding and better functionality of the protein.  
 Surprisingly, there did not appear to be a relationship between strength of 
SUMO-binding and protein function (HR capability) of the various mutants 
investigated (Figure 3.5d). Whilst mutants 4567-O, 67-O and 167-O showed both 
good SUMO-2 binding and HR rescue ability, mutants 123-O and 2345-O exhibited 
good SUMO-2 binding with only limited HR rescue capabilities. A potential 
explanation for this anomaly may lie within the structure of SENP7. Whilst it has 
been shown that SENP7 is highly flexible outside of its N-terminal catalytic domain, 
it is possible that the 123-O and 2345-O mutants can bind SUMO effectively, but 
cannot efficiently deliver it to the catalytic site for cleavage. Conversely, when SIMs 
6 and 7 bind SUMO they may be able to deliver SUMO to the catalytic site with 
greater efficiency. SIMs 6 and 7 being in closer proximity to the catalytic domain in 
terms of primary amino acid sequence although applicably logical to such a theory, is 
probably of little significance as SENP7 is thought to be highly flexible outside of the 
catalytic domain. Only structural analysis of the whole protein in conjugation to 
SUMO-conjugated proteins will resolve such a theory, which to date has been beyond 
the reach of crystallographic studies. It therefore seems the story of SIM:SUMO 
interaction within SENP7 is probably a rather complex one. Whilst some trends have 
been observed in the results, no SIM can be defined as completely redundant or 
completely essential in SUMO binding or SENP7 function. 
 Finally, our study was able to reveal a possible substrate of SENP7’s for 
deSUMOylation, KAP-1. KAP-1 is a nuclear protein, which amongst its known roles 
in the regulation of transcriptional repression and activation, has been shown to be 
involved in the DDR [69]. It co-localises with 53BP1, H2AX, BRCA1, and TopBP1 
(DNA damage response proteins) at DNA lesions [67]. KAP-1 is also known to 
interact with HP1-α through the presence of a HP1 box, like that of SENP7 [68]. The 
differences in KAP-1 interaction seen with the various forms of SENP7 could be 
explained as follows. The little to no interaction of WT SENP7 with KAP-1 is 
explained by the fact that SENP7 will be binding and cleaving the SUMO chains 
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attached to KAP-1 very dynamically. CA SENP7 shows strong interaction as the two 
will bind, but no cleavage activity is possible to release KAP-1. SIMless SENP7 
shows similar levels of interaction to the CA mutant. This is not through SENP7’s 
interaction with the SUMO-modified KAP-1, but instead due to SENP7 and KAP-1 
remaining in a complex through their independent HP1-α binding. The reduced 
interaction seen with the SIMlessCA mutant cannot yet be explained, however, it is 
possible that this could be explained by further complexities and interactions not yet 
known within the complex. 
 
SUMO
-2/3
SUMO
-2/3
SUMO
-2/3
SUMO
-2/3
SENP7
KAP-1
HP1-α
Cleavage of the 
SUMO-2/3 chain 
modifying KAP-1
 
Figure 4.0 – Schematic Detailing the Possible Interactions of SENP7, KAP-1 and 
HP1-α. SENP7 interacts with the poly-SUMO-2/3 chain modifying KAP-1 through 
its SIMs and can cleave the chain. The HP1 boxes of SENP7 and KAP-1 allow 
interaction with HP1-α. 
 
4.1 Limitations 
To further analyse the requirement of each individual SIM for protein function 
SENP7 constructs in which SIM 2, SIM 3, SIM 6 and SIM 7 were mutated alone 
would have been useful in determining whether any SIM is completely redundant. 
Conversely, it would also have allowed the analysis of SIM 6 and SIM 7 individually. 
These SIMs were shown to be of greater importance than others, however, in all of 
the mutants constructed they existed as a pair (either both being mutated, or both 
being functional). Unfortunately, these mutants could not initially be made due to the 
limited availability of forward and reverse SENP7 primers required in their synthesis. 
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When it came to the point in which their importance was realised not enough time 
remained within the project to construct these mutants and analyse their behaviour. 
Indeed, the length of the 3 month short project was a limiting factor within the study. 
 Whilst stable lines were eventually available for the WT, CA, SIMless and 
SIMlessCA constructs of SENP7, they were not for all of the SIM mutants. Stable cell 
lines would have eased the production of large amounts of SENP7 protein required 
for the co-IP experiments. 
 
4.2 Future Work 
To order the required forward and reverse primers required to create the single SIM 
mutants would circumvent the limitations of this study mentioned above. The making 
of stable cell lines for the SIM mutants constructs had started before the end of my 
project, however, not in time for my use. Successful creation of these cell lines would 
have been very useful. Further repeats of the HR assay would verify the data already 
collected and help make stronger conclusions upon which SIMs were most important 
for SUMO-binding and function of SENP7. 
 It would also be of great interest to carry out further investigation of the 
interaction between SENP7 and KAP-1 and particularly if it is significant to the DDR. 
DNA damage could be induced within cells (e.g. through ionizing irradiation) and the 
levels of SENP7 and KAP-1 interaction monitored at various time points by co-
immunoprecipitation studies. This would give an indication to whether these proteins’ 
interactions are increased or decreased during DNA damage response and if so this 
would suggest a role in the DDR. 
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